[{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 E2F6","url":"http://egg.wustl.edu/d/hg19/GSM803469_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24060","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"E2F6","antibody antibodydescription":"Rabbit polyclonal IgG, epitope corresponding to a.a. 232-281 mapping at the C-terminus of E2F-6 of human origin.","antibody targetdescription":"This gene encodes a member of the E2F transcription factor protein family. E2F family members play a crucial role in control of the cell cycle and of the action of tumor suppressor proteins. They are also a target of the transforming proteins of small DNA tumor viruses. Many E2F proteins contain several evolutionarily conserved domains: a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. The encoded protein of this gene is atypical because it lacks the transactivation and tumor suppressor protein association domains. It contains a modular suppression domain and is an inhibitor of E2F-dependent transcription. The protein is part of a multimeric protein complex that contains a histone methyltransferase and the transcription factors Mga and Max. Multiple transcript variants have been reported for this gene, but it has not been clearly demonstrated that they encode valid isoforms (RefSeq).","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-22823","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.2","protocol description":"2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)","controlid":"SL1396","labexpid":"SL2948","replicate":"1","replicate description":"tier 1","original_filename":"GSM803469_hg19_wgEncodeHaibTfbsK562E2f6sc22823V0416102RawRep1.bigWig"},"geolst":["GSM803469"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 MEF2A","url":"http://egg.wustl.edu/d/hg19/GSM803379_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24030","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"MEF2A","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping at the C-terminus of MEF-2 of human origin.","antibody targetdescription":"The protein encoded by this gene is a DNA-binding transcription factor that activates many muscme-specific, growth factor-induced, and stress-induced genes.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-313","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL1794","replicate":"1","replicate description":"tier 1","original_filename":"GSM803379_hg19_wgEncodeHaibTfbsK562Mef2aV0416101RawRep1.bigWig"},"geolst":["GSM803379"]},{"type":"bigWig","name":"Stanford ChipSeq K562 GTF2F1","url":"http://egg.wustl.edu/d/hg19/GSM935501_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24651","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"GTF2F1_(AB28179)","antibody antibodydescription":"Rabbit polyclonal to TFIIF - Recombinant full length protein - RAP 74 subunit of TF11F. Antibody Target: GTF2F1","antibody targetdescription":"RNA polymerase II transcription factor TFIIF is a heterodimer with 2 subunits: one, referred to as RAP74. TFIIF appears to assist TFIIB in recruiting RNA polymerase II into a preinitiation complex. It also affects RNA transcription by suppressing transient pausing of the polymerase at locations on the DNA template.","antibody vendorname":"Abcam","antibody vendorid":"ab28179","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935501_hg19_wgEncodeSydhTfbsK562Gtf2f1ab28179IggrabSig.bigWig"},"geolst":["GSM935501"]},{"type":"bigWig","name":"SunyAlbany RipSeq K562 ELAVL1","url":"http://egg.wustl.edu/d/hg19/GSM944523_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24076","30021"],"details":{"lab":"SunyAlbany","lab description":"Tenenbaum - SUNY at Albany","datatype":"RipSeq","datatype description":"RNA IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"ELAVL1","antibody antibodydescription":"1) Mouse monocloanal vs HuR, Hel-N1, HuC and HuD of mus, rat, hum and Xenopus origin","antibody targetdescription":"(Embryonic lethal, abnormal vision, Drosophila)-like 1 (Huantigen R) (Homo sapiens)","antibody vendorname":"1) Santa Cruz Biotech","antibody vendorid":"SC-5261","labversion":"SC_5261 antibody","replicate":"1","original_filename":"GSM944523_hg19_wgEncodeSunyRipSeqK562Elavl1SigRep2.bigWig"},"geolst":["GSM944523"]},{"type":"bigWig","name":"USC ChipSeq K562 ZNF263","url":"http://egg.wustl.edu/d/hg19/GSM935532_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24625","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"ZNF263","antibody antibodydescription":"Mouse polyclonal. Antibody Target: ZNF263","antibody targetdescription":"ZNF263 (NP_005732, 201 a.a. ~ 299 a.a) partial recombinant protein with GST tag.","antibody vendorname":"Novus Biologicals","antibody vendorid":"H00010127-A01","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","labversion":"Fragmented using Bioruptor, precipitated with StaphA","replicate":"1","softwareversion":"PeakSeq1.0 (fdr 0.001)","original_filename":"GSM935532_hg19_wgEncodeSydhTfbsK562Znf263UcdSig.bigWig"},"geolst":["GSM935532"]},{"type":"bigWig","name":"Stanford ChipSeq K562 MAZ","url":"http://egg.wustl.edu/d/hg19/GSM935337_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24601","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"MAZ_(ab85725)","antibody antibodydescription":"Rabbit polyclonal, immunogen is synthetic peptide, corresponding to a region within amino acids 427-477 of Human MAZ, GenBank BAA33064.1. Antibody Target: MAZ","antibody targetdescription":"May function as a transcription factor with dual roles in transcription initiation and termination. Binds to two sites, ME1a1 and ME1a2, within the MYC promoter having greater affinity for the former. Also binds to multiple G/C-rich sites within the promoter of the Sp1 family of transcription factors.","antibody vendorname":"Abcam","antibody vendorid":"ab85725","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935337_hg19_wgEncodeSydhTfbsK562Mazab85725IggrabSig.bigWig"},"geolst":["GSM935337"]},{"type":"bigWig","name":"Harvard ChipSeq K562 BDP1","url":"http://egg.wustl.edu/d/hg19/GSM935594_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24654","30020"],"details":{"lab":"Harvard","lab description":"Struhl - Harvard University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"BDP1","antibody antibodydescription":"Rabbit polyclonal - Antiserum 2663 was raised by immunizing rabbits with synthetic peptide CSDRYRIYKAQKLRE (human Bdp1 residues 139?153) coupled to KLH. Antibody Target: BDP1","antibody targetdescription":"'B double-prime 1', subunit of RNA polymerase III transcription initiation factor IIIB","antibody vendorname":"Donated by Dr. RJ White, The Beatson Institute for Cancer Research","antibody vendorid":"2663","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","labversion":"fragmented with both a probe sonicator and a Misonix sonicator, and precipitated with protein A sepharose beads","replicate":"1","original_filename":"GSM935594_hg19_wgEncodeSydhTfbsK562Bdp1StdSig.bigWig"},"geolst":["GSM935594"]},{"type":"bigWig","name":"Yale ChipSeq K562 IFNg6h","url":"http://egg.wustl.edu/d/hg19/GSM935599_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24004","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNg6h","treatment description":"Interferon gamma treatment - 6 hours (Snyder)","antibody":"c-Myc","antibody antibodydescription":"rabbit polyclonal to amino acids 1-262 of c-Myc human origin. Antibody Target: c-Myc","antibody targetdescription":"transcription factor","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-764","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000658","labversion":"remapped from hg18","replicate":"1","original_filename":"GSM935599_hg19_wgEncodeSydhTfbsK562CmycIfng6hStdSig.bigWig"},"geolst":["GSM935599"]},{"type":"bigWig","name":"Yale ChipSeq K562 IFNa30","url":"http://egg.wustl.edu/d/hg19/GSM935475_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24003","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNa30","treatment description":"30 m of Interferon alpha (Snyder)","antibody":"Pol2","antibody antibodydescription":"mouse monoclonal, clone 8WG16. Antibody Target: POL2","antibody targetdescription":"RNA Polymerase II","antibody vendorname":"Covance","antibody vendorid":"MMS-126R","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000655","labversion":"Illumina 2.0, low confidence sequences excluded","replicate":"1","original_filename":"GSM935475_hg19_wgEncodeSydhTfbsK562Pol2Ifna30StdSig.bigWig"},"geolst":["GSM935475"]},{"type":"bigWig","name":"Stanford ChipSeq K562 Bach1","url":"http://egg.wustl.edu/d/hg19/GSM935576_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24629","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Bach1_(sc-14700)","antibody antibodydescription":"BACH1 (C-20) is an affinity purified goat polyclonal antibody raised against a peptide mapping near the C-terminus of BACH1 of human origin. Antibody Target: Bach1","antibody targetdescription":"This gene encodes a transcription factor that belongs to the cap'n'collar type of basic region leucine zipper factor family (CNC-bZip). The encoded protein contains broad complex, tramtrack, bric-a-brac/poxvirus and zinc finger (BTB/POZ) domains, which is atypical of CNC-bZip family members. These BTB/POZ domains facilitate protein-protein interactions and formation of homo- and/or hetero-oligomers. When this encoded protein forms a heterodimer with MafK, it functions as a repressor of Maf recognition element (MARE) and transcription is repressed. Multiple alternatively spliced transcript variants have been identified for this gene. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-14700","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935576_hg19_wgEncodeSydhTfbsK562Bach1sc14700IggrabSig.bigWig"},"geolst":["GSM935576"]},{"type":"bigWig","name":"Stanford ChipSeq K562 TBLR1","url":"http://egg.wustl.edu/d/hg19/GSM935574_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24628","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"TBLR1_(NB600-270)","antibody antibodydescription":"Rabbit polyclonal, immunogen: A synthetic peptide that maps to a region between residues 100 and 150 of human TBL1-related Protein 1 using the numbering given in SwissProt entry Q9BZK7.","antibody targetdescription":"F-box-like protein involved in the recruitment of the ubiquitin/19S proteasome complex to nuclear receptor-regulated transcription units. Plays an essential role in transcription activation mediated by nuclear receptors. Probably acts as integral component of the N-Cor corepressor complex that mediates the recruitment of the 19S proteasome complex, leading to the subsequent proteasomal degradation of N-Cor complex, thereby allowing cofactor exchange, and transcription activation","antibody vendorname":"Novus Biologicals","antibody vendorid":"NB600-270","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935574_hg19_wgEncodeSydhTfbsK562Tblr1nb600270IggrabSig.bigWig"},"geolst":["GSM935574"]},{"type":"bigWig","name":"Stanford ChipSeq K562 CEBPB","url":"http://egg.wustl.edu/d/hg19/GSM935499_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24624","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"CEBPB","antibody antibodydescription":"Rabbit polyclonal IgG. Antibody Target: CEBPB","antibody targetdescription":"epitope mapping at the C-terminus of C/EBP-beta of rat origin","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-150","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935499_hg19_wgEncodeSydhTfbsK562CebpbIggrabSig.bigWig"},"geolst":["GSM935499"]},{"type":"bigWig","name":"Stanford ChipSeq K562 UBF","url":"http://egg.wustl.edu/d/hg19/GSM935338_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24661","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"UBF_(sc-13125)","antibody antibodydescription":"UBF (F-9) is a mouse monoclonal antibody raised against amino acids 1-220 of UBF of human origin. Antibody Target: UBF","antibody targetdescription":"Upstream binding factor (UBF) is a transcription factor required for expression of the 18S, 5.8S, and 28S ribosomal RNAs, along with SL1 (a complex of TBP (MIM 600075) and multiple TBP-associated factors or 'TAFs'). Two UBF polypeptides, of 94 and 97 kD, exist in the human (Bell et al., 1988 (PubMed 3413483)). UBF is a nucleolar phosphoprotein with both DNA binding and transactivation domains. Sequence-specific DNA binding to the core and upstream control elements of the human rRNA promoter is mediated through several HMG boxes","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-13125","control":"IgG-mus","control description":"Input signal from Normal Mouse IgG ChIP-seq.","controlid":"wgEncodeEH000726","replicate":"1","original_filename":"GSM935338_hg19_wgEncodeSydhTfbsK562Ubfsc13125IggmusSig.bigWig"},"geolst":["GSM935338"]},{"type":"bigWig","name":"Stanford ChipSeq K562 p300","url":"http://egg.wustl.edu/d/hg19/GSM935494_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24011","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"p300_(SC-48343)","antibody antibodydescription":"mouse monoclonal raised against amino acids 774-1045 of p300 of human origin. Antibody Target: P300","antibody targetdescription":"Encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. Functions as histone acetyltransferase and regulates transcription via chromatin remodeling. Acetylates all four core histones in nucleosomes. Mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-48343","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935494_hg19_wgEncodeSydhTfbsK562P300sc584sc48343IggrabSig.bigWig"},"geolst":["GSM935494"]},{"type":"bigWig","name":"Stanford ChipSeq K562 TAL1","url":"http://egg.wustl.edu/d/hg19/GSM935496_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24675","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"TAL1_(SC-12984)","antibody antibodydescription":"goat polyclonal antibody","antibody targetdescription":"TAL1 (also designated SCL) is a serine phosphoprotein and basic helix-loop-helix transcription factor known to regulate embryonic hematopoiesis.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-12984","control":"IgG-mus","control description":"Input signal from Normal Mouse IgG ChIP-seq.","controlid":"wgEncodeEH000726","replicate":"1","original_filename":"GSM935496_hg19_wgEncodeSydhTfbsK562Tal1sc12984IggmusSig.bigWig"},"geolst":["GSM935496"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 TAF1","url":"http://egg.wustl.edu/d/hg19/GSM803431_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24028","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"TAF1","antibody antibodydescription":"Mouse monoclonal (p250)","antibody targetdescription":"TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa. Also designated TAF250.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-735","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2941","replicate":"1","replicate description":"tier 1","original_filename":"GSM803431_hg19_wgEncodeHaibTfbsK562Taf1V0416101RawRep2.bigWig"},"geolst":["GSM803431"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 TAF1","url":"http://egg.wustl.edu/d/hg19/GSM803431_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24028","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"TAF1","antibody antibodydescription":"Mouse monoclonal (p250)","antibody targetdescription":"TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa. Also designated TAF250.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-735","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2941","replicate":"1","replicate description":"tier 1","original_filename":"GSM803431_hg19_wgEncodeHaibTfbsK562Taf1V0416101RawRep1.bigWig"},"geolst":["GSM803431"]},{"type":"bigWig","name":"Harvard ChipSeq K562 BRF2","url":"http://egg.wustl.edu/d/hg19/GSM935490_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24674","30020"],"details":{"lab":"Harvard","lab description":"Struhl - Harvard University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"BRF2","antibody antibodydescription":"Antibody 4295 against Brf2 was raised by immunizing rabbits with keyhole limpet hemocyanin coupled to synthetic peptides VSRSQQRGLRRVRDLC and SDSEIEQYLRTPQEVR, corresponding to human Brf2 residues 66-80 and 385-400, respectively. Antibody Target: BRF2","antibody targetdescription":"Brf2 is a component of an alternate form of the RNA Polymerase III transcription factor TFIIIB.","antibody vendorname":"Donated by Dr. RJ White, The Beatson Institute for Cancer Research","antibody vendorid":"4295","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","replicate":"1","original_filename":"GSM935490_hg19_wgEncodeSydhTfbsK562Brf2StdSig.bigWig"},"geolst":["GSM935490"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 SIX5","url":"http://egg.wustl.edu/d/hg19/GSM803383_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24016","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"SIX5","antibody antibodydescription":"Six5 (K-20) Goat polyclonal IgG, 200?g/ml. Epitope mapping near the C-terminus of Six5 of human origin. Recommended for detection of Six5 of human origin by WB, IF and ELISA","antibody targetdescription":"The protein encoded by this gene is a homeodomain-containing transcription factor that appears to function in the regulation of organogenesis. This gene is located downstream of the dystrophia myotonica-protein kinase gene. Mutations in this geneare a cause of branchiootorenal syndrome type 2.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-55706","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL518","labexpid":"SL842","replicate":"1","replicate description":"tier 1","original_filename":"GSM803383_hg19_wgEncodeHaibTfbsK562Six5Pcr1xRawRep2.bigWig"},"geolst":["GSM803383"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 SIX5","url":"http://egg.wustl.edu/d/hg19/GSM803383_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24016","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"SIX5","antibody antibodydescription":"Six5 (K-20) Goat polyclonal IgG, 200?g/ml. Epitope mapping near the C-terminus of Six5 of human origin. Recommended for detection of Six5 of human origin by WB, IF and ELISA","antibody targetdescription":"The protein encoded by this gene is a homeodomain-containing transcription factor that appears to function in the regulation of organogenesis. This gene is located downstream of the dystrophia myotonica-protein kinase gene. Mutations in this geneare a cause of branchiootorenal syndrome type 2.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-55706","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL518","labexpid":"SL842","replicate":"1","replicate description":"tier 1","original_filename":"GSM803383_hg19_wgEncodeHaibTfbsK562Six5Pcr1xRawRep1.bigWig"},"geolst":["GSM803383"]},{"type":"bigWig","name":"Stanford ChipSeq K562 c-Myc","url":"http://egg.wustl.edu/d/hg19/GSM935516_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24004","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"c-Myc","antibody antibodydescription":"rabbit polyclonal to amino acids 1-262 of c-Myc human origin. Antibody Target: c-Myc","antibody targetdescription":"transcription factor","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-764","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935516_hg19_wgEncodeSydhTfbsK562CmycIggrabSig.bigWig"},"geolst":["GSM935516"]},{"type":"bigWig","name":"Stanford ChipSeq K562 ZC3H11A","url":"http://egg.wustl.edu/d/hg19/GSM1003610_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24698","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"ZC3H11A_(NB100-74650)","antibody antibodydescription":"Rabbit polyclonal antibody. The immunogen recognized by this antibody maps to a region between residue 250 and 300 of human zinc finger CCCH-type containing 11A.","antibody targetdescription":"ZC3H11A is a C3H1-type zinc finger protein. ZC3H11A has been identified as a protein that is phosphorylated upon DNA damage by ATM or ATR. The function of ZC3H11A remains uncharacterized.","antibody vendorname":"NovusBio","antibody vendorid":"NB100-74650","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","labversion":"PeakSeq1.0","original_filename":"GSM1003610_hg19_wgEncodeSydhTfbsK562Zc3h11anb10074650IggrabSig.bigWig"},"geolst":["GSM1003610"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 TEAD4","url":"http://egg.wustl.edu/d/hg19/GSM1010895_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24680","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Mouse monoclonal IgG, raised against recombinant protein TEF-3 (TEAD4) of human origin. Antibody Target: TEAD4","antibody targetdescription":"Member of the transcriptional enhancer factor (TEF) family of transcription factors, which contain the TEA/ATTS DNA-binding domain. It is preferentially expressed in the skeletal muscle, and binds to the M-CAT regulatory element found in promoters of muscle-specific genes to direct their gene expression.","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-101184","controlid":"SL6023","labexpid":"SL7841,SL7571","softwareversion":"MACS","cell sex":"F","antibody":"TEAD4_(SC-101184)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010895_hg19_wgEncodeHaibTfbsK562Tead4sc101184V0422111RawRep1.bigWig"},"geolst":["GSM1010895"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 TEAD4","url":"http://egg.wustl.edu/d/hg19/GSM1010895_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24680","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Mouse monoclonal IgG, raised against recombinant protein TEF-3 (TEAD4) of human origin. Antibody Target: TEAD4","antibody targetdescription":"Member of the transcriptional enhancer factor (TEF) family of transcription factors, which contain the TEA/ATTS DNA-binding domain. It is preferentially expressed in the skeletal muscle, and binds to the M-CAT regulatory element found in promoters of muscle-specific genes to direct their gene expression.","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-101184","controlid":"SL6023","labexpid":"SL7841,SL7571","softwareversion":"MACS","cell sex":"F","antibody":"TEAD4_(SC-101184)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010895_hg19_wgEncodeHaibTfbsK562Tead4sc101184V0422111RawRep2.bigWig"},"geolst":["GSM1010895"]},{"type":"bigWig","name":"Harvard ChipSeq K562 GTF2B","url":"http://egg.wustl.edu/d/hg19/GSM935394_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24614","30020"],"details":{"lab":"Harvard","lab description":"Struhl - Harvard University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"GTF2B","antibody antibodydescription":"rabbit polyclonal IgG, 200 ?g/ml. epitope mapping near the C-terminus of TFIIB of human origin. Antibody Target: GTF2B","antibody targetdescription":"DNA- binding general transcription factor","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-225","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","labversion":"remapped from hg18","replicate":"1","original_filename":"GSM935394_hg19_wgEncodeSydhTfbsK562Gtf2bStdSig.bigWig"},"geolst":["GSM935394"]},{"type":"bigWig","name":"Harvard ChipSeq K562 NELFe","url":"http://egg.wustl.edu/d/hg19/GSM935392_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24646","30020"],"details":{"lab":"Harvard","lab description":"Struhl - Harvard University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"NELFe","antibody antibodydescription":"NELFe (RDBP). Antibody Target: NELFe","antibody targetdescription":"NELFe (RDBP) is a part of the negative elongation factor complex which binds to RNAPII to suppress elongation.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-32912","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","replicate":"1","original_filename":"GSM935392_hg19_wgEncodeSydhTfbsK562NelfeStdSig.bigWig"},"geolst":["GSM935392"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 BCL3","url":"http://egg.wustl.edu/d/hg19/GSM803518_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24020","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"BCL3","antibody antibodydescription":"Bcl-3(C-14) is an affinity purified rabbit polyclonal antibody raised against a peptide mapping at the C-terminus of Bcl-3 of human origin. Recommended for detection of Bcl-3 of m, r and h origin by WB, IP, IF and ELISA.","antibody targetdescription":"This gene is a proto-oncogene candidate. It is identified by its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukemia. The protein encoded by this gene contains seven ankyrin repeats, which are most closely related to those found in I kappa B proteins. This protein functions as a transcriptional co-activator that activates through its association with NF-kappa B homodimers. The expression of this gene can be induced by NF-kappa B, which forms a part of the autoregulatory loop that controls the nuclear residence of p50 NF-kappa B. (Provided by RefSeq).","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-185","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL2455","labexpid":"SL1196","replicate":"1","replicate description":"tier 1","original_filename":"GSM803518_hg19_wgEncodeHaibTfbsK562Bcl3Pcr1xRawRep1.bigWig"},"geolst":["GSM803518"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 BCL3","url":"http://egg.wustl.edu/d/hg19/GSM803518_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24020","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"BCL3","antibody antibodydescription":"Bcl-3(C-14) is an affinity purified rabbit polyclonal antibody raised against a peptide mapping at the C-terminus of Bcl-3 of human origin. Recommended for detection of Bcl-3 of m, r and h origin by WB, IP, IF and ELISA.","antibody targetdescription":"This gene is a proto-oncogene candidate. It is identified by its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukemia. The protein encoded by this gene contains seven ankyrin repeats, which are most closely related to those found in I kappa B proteins. This protein functions as a transcriptional co-activator that activates through its association with NF-kappa B homodimers. The expression of this gene can be induced by NF-kappa B, which forms a part of the autoregulatory loop that controls the nuclear residence of p50 NF-kappa B. (Provided by RefSeq).","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-185","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL2455","labexpid":"SL1196","replicate":"1","replicate description":"tier 1","original_filename":"GSM803518_hg19_wgEncodeHaibTfbsK562Bcl3Pcr1xRawRep2.bigWig"},"geolst":["GSM803518"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 BCLAF1","url":"http://egg.wustl.edu/d/hg19/GSM803515_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24064","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"BCLAF1_(SC-101388)","antibody antibodydescription":"Mouse monoclonal IgG, raised against a synthetic peptide corresponding to a.a. 900-909 of BCLAF1 of human origin.","antibody targetdescription":"This gene encodes a transcriptional repressor that interacts with several members of the BCL2 family of proteins. Overexpression of this protein induces apoptosis, which can be suppressed by co-expression of BCL2 proteins (RefSeq).","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-101388","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL2455","labexpid":"SL1273","replicate":"1","replicate description":"tier 1","original_filename":"GSM803515_hg19_wgEncodeHaibTfbsK562Bclaf101388Pcr1xRawRep1.bigWig"},"geolst":["GSM803515"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 BCLAF1","url":"http://egg.wustl.edu/d/hg19/GSM803515_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24064","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"BCLAF1_(SC-101388)","antibody antibodydescription":"Mouse monoclonal IgG, raised against a synthetic peptide corresponding to a.a. 900-909 of BCLAF1 of human origin.","antibody targetdescription":"This gene encodes a transcriptional repressor that interacts with several members of the BCL2 family of proteins. Overexpression of this protein induces apoptosis, which can be suppressed by co-expression of BCL2 proteins (RefSeq).","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-101388","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL2455","labexpid":"SL1273","replicate":"1","replicate description":"tier 1","original_filename":"GSM803515_hg19_wgEncodeHaibTfbsK562Bclaf101388Pcr1xRawRep2.bigWig"},"geolst":["GSM803515"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 PU.1","url":"http://egg.wustl.edu/d/hg19/GSM803384_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24033","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"PU.1","antibody antibodydescription":"Rabbit Polyclonal IgG","antibody targetdescription":"PU.1 (H-135)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-22805","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL518","labexpid":"SL646","replicate":"1","replicate description":"tier 1","original_filename":"GSM803384_hg19_wgEncodeHaibTfbsK562Pu1Pcr1xRawRep1.bigWig"},"geolst":["GSM803384"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 PU.1","url":"http://egg.wustl.edu/d/hg19/GSM803384_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24033","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"PU.1","antibody antibodydescription":"Rabbit Polyclonal IgG","antibody targetdescription":"PU.1 (H-135)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-22805","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL518","labexpid":"SL646","replicate":"1","replicate description":"tier 1","original_filename":"GSM803384_hg19_wgEncodeHaibTfbsK562Pu1Pcr1xRawRep2.bigWig"},"geolst":["GSM803384"]},{"type":"bigWig","name":"USC ChipSeq K562 KAP1","url":"http://egg.wustl.edu/d/hg19/GSM935464_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24036","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"KAP1","antibody antibodydescription":"rabbit polyclonal. Antibody Target: KAP1","antibody targetdescription":"KRAB Associated Protein 1, helps regulate transcriptional repression","antibody vendorname":"Abcam","antibody vendorid":"ab10483","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","replicate":"1","original_filename":"GSM935464_hg19_wgEncodeSydhTfbsK562Kap1UcdSig.bigWig"},"geolst":["GSM935464"]},{"type":"bigWig","name":"Yale ChipSeq K562 IFNa6h","url":"http://egg.wustl.edu/d/hg19/GSM935466_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24004","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNa6h","treatment description":"Interferon alpha treatment - 6 hours (Snyder)","antibody":"c-Myc","antibody antibodydescription":"rabbit polyclonal to amino acids 1-262 of c-Myc human origin. Antibody Target: c-Myc","antibody targetdescription":"transcription factor","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-764","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000656","labversion":"remapped from hg18, Illumina 2.0, low confidence sequences excluded","replicate":"1","original_filename":"GSM935466_hg19_wgEncodeSydhTfbsK562CmycIfna6hStdSig.bigWig"},"geolst":["GSM935466"]},{"type":"bigWig","name":"Stanford ChipSeq K562 Pol2(phosphoS2)","url":"http://egg.wustl.edu/d/hg19/GSM935645_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24634","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Pol2(phosphoS2)","antibody antibodydescription":"Rabbit polyclonal against peptide conjugated to KLH derived from within residues 1600 - 1700 of S. cerevisiae RNA polymerase II CTD repeat YSPTSPS, phosphorylated at S2. Antibody Target: POL2S2","antibody targetdescription":"RNA polymerase II, large subunit- specific for phosphorylated C-terminal domain.","antibody vendorname":"Abcam","antibody vendorid":"ab5095","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","replicate":"1","original_filename":"GSM935645_hg19_wgEncodeSydhTfbsK562Pol2s2StdSig.bigWig"},"geolst":["GSM935645"]},{"type":"bigWig","name":"Stanford ChipSeq K562 IFNa30","url":"http://egg.wustl.edu/d/hg19/GSM935546_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24652","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNa30","treatment description":"30 m of Interferon alpha (Snyder)","antibody":"IRF1","antibody antibodydescription":"IRF-1 (C-20) is an affinity purified rabbit polyclonal antibody raised against a peptide mapping at the C-terminus of IRF-1 of human origin. Antibody Target: IRF1","antibody targetdescription":"Interferon regulatory factor 1 is a member of the interferon regulatory transcription factor (IRF) family. IRF1 serves as an activator of interferons alpha and beta transcription and also functions as a transcription activator of genes induced by interferons alpha, beta, and gamma. IRF1 has been shown to play roles in regulating apoptosis and tumor suppression.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-497","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000655","replicate":"1","original_filename":"GSM935546_hg19_wgEncodeSydhTfbsK562Irf1Ifna30StdSig.bigWig"},"geolst":["GSM935546"]},{"type":"bigWig","name":"Harvard ChipSeq K562 HMGN3","url":"http://egg.wustl.edu/d/hg19/GSM935544_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24676","30020"],"details":{"lab":"Harvard","lab description":"Struhl - Harvard University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"HMGN3","antibody antibodydescription":"Rabbit polyclonal. Raised against an amino acids 60 to 99 of human HMGN3. Vendor recommeds its use for detection of HMGN3 in human samples using immunohistochemistry. Antibody Target: HMGN3","antibody targetdescription":"HMGN3 is a high-mobility group protein. These proteins are small, 8 to 11 kDa, ubiquitous proteins believed to play a role in chromatin structure. HMGNs bind to nucleosomes between the histone core and DNA and reduce chromatin compaction. As a result HMGNs, HMGN3 included, are believed to increase access to DNA for DNA replication, repair and transcription. HMGN3 has specifically been implicated in the action of Thyroid horomone receptors.","antibody vendorname":"Novus Biologicals","antibody vendorid":"NB100-61076","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","replicate":"1","original_filename":"GSM935544_hg19_wgEncodeSydhTfbsK562Hmgn3StdSig.bigWig"},"geolst":["GSM935544"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 Pol2","url":"http://egg.wustl.edu/d/hg19/GSM803410_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24003","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"Pol2","antibody antibodydescription":"mouse monoclonal, clone 8WG16","antibody targetdescription":"RNA Polymerase II","antibody vendorname":"Covance","antibody vendorid":"MMS-126R","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3819","replicate":"1","replicate description":"tier 1","original_filename":"GSM803410_hg19_wgEncodeHaibTfbsK562Pol2V0416101RawRep1.bigWig"},"geolst":["GSM803410"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 Pol2","url":"http://egg.wustl.edu/d/hg19/GSM803410_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24003","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"Pol2","antibody antibodydescription":"mouse monoclonal, clone 8WG16","antibody targetdescription":"RNA Polymerase II","antibody vendorname":"Covance","antibody vendorid":"MMS-126R","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3819","replicate":"1","replicate description":"tier 1","original_filename":"GSM803410_hg19_wgEncodeHaibTfbsK562Pol2V0416101RawRep2.bigWig"},"geolst":["GSM803410"]},{"type":"bigWig","name":"Stanford ChipSeq K562 UBTF","url":"http://egg.wustl.edu/d/hg19/GSM935642_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24659","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"UBTF_(SAB1404509)","antibody antibodydescription":"Mouse monoclonal, immunogen:UBTF (NP_055048, 551 a.a. ~ 651 a.a) partial recombinant protein with GST tag. Antibody Target: UBTF","antibody targetdescription":"Upstream binding factor (UBF) is a transcription factor required for expression of the 18S, 5.8S, and 28S ribosomal RNAs, along with SL1 (a complex of TBP (MIM 600075) and multiple TBP-associated factors or 'TAFs'). Two UBF polypeptides, of 94 and 97 kD, exist in the human (Bell et al., 1988 (PubMed 3413483)). UBF is a nucleolar phosphoprotein with both DNA binding and transactivation domains. Sequence-specific DNA binding to the core and upstream control elements of the human rRNA promoter is mediated through several HMG boxes","antibody vendorname":"Sigma-Aldrich","antibody vendorid":"SAB1404509","control":"IgG-mus","control description":"Input signal from Normal Mouse IgG ChIP-seq.","controlid":"wgEncodeEH000726","replicate":"1","original_filename":"GSM935642_hg19_wgEncodeSydhTfbsK562Ubtfsab1404509IggmusSig.bigWig"},"geolst":["GSM935642"]},{"type":"bigWig","name":"Broad ChipSeq K562 SETDB1","url":"http://egg.wustl.edu/d/hg19/GSM1003452_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24619","30003"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Rabbit polyclonal. Antibody Target: SETDB1","antibody targetdescription":"SET domain, bifurcated 1, the SET domain is a highly conserved, approximately 150-amino acid motif implicated in the modulation of chromatin structure","antibody vendorname":"Proteintech Group","antibody vendorid":"11231-1-AP","controlid":"K562/None/Input/std","replicate":"1","softwareversion":"ScriptureVPaperR3","cell sex":"F","antibody":"SETDB1","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","labversion":"Illumina_GA2x","labversion description":"Illumina Genome Analyzer IIx","original_filename":"GSM1003452_hg19_wgEncodeBroadHistoneK562Setdb1Sig.bigWig"},"geolst":["GSM1003452"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 Egr-1","url":"http://egg.wustl.edu/d/hg19/GSM803414_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24050","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"Egr-1","antibody antibodydescription":"Rabbit polyclonal, EGR-1 (588).","antibody targetdescription":"Egr-1, Egr-2, Egr-3 and Egr-4 are nuclear transcription factors belonging to the Egr C2H2-type zinc-finger protein family and containing three C2H2-type zinc fingers. As immediate early proteins, Egr transcription factors are rapidly induced by diverse extracellular stimuli. Egr proteins are subject to tight differential control through diverse mechanisms at several levels of regulation including transcriptional, translational and post-translational (including glyco- sylation, phosphorylation and redox) mechanisms and protein-protein inter- action. Egr-1 binds to the DNA sequence 5'-CGCCCCCGC-3' (EGR-site), there- by activating transcription of target genes whose products are required for mitogenisis and differentiation. Egr-2 binds specific DNA sites located in the promoter region of HoxA4. Egr-2 defects cause congenital hypomyelination neuropathy (also designated Charcot-Marie-tooth disease) and Dejerine- Sottas neuropathology (also designated hereditary motor and sensory neuro- pathy III. Egr-3 is involved in muscle spindle development and is expressed in T cells 20 minutes following activation. EGR-4 binds to the EGR consensus motif GCGTGGGCG, functions as a transcriptional repressor, and displays autoregulatory activities, downregulating its on gene promoter in a dose dependent manner.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-110","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3164","replicate":"1","replicate description":"tier 1","original_filename":"GSM803414_hg19_wgEncodeHaibTfbsK562Egr1V0416101RawRep1.bigWig"},"geolst":["GSM803414"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 Egr-1","url":"http://egg.wustl.edu/d/hg19/GSM803414_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24050","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"Egr-1","antibody antibodydescription":"Rabbit polyclonal, EGR-1 (588).","antibody targetdescription":"Egr-1, Egr-2, Egr-3 and Egr-4 are nuclear transcription factors belonging to the Egr C2H2-type zinc-finger protein family and containing three C2H2-type zinc fingers. As immediate early proteins, Egr transcription factors are rapidly induced by diverse extracellular stimuli. Egr proteins are subject to tight differential control through diverse mechanisms at several levels of regulation including transcriptional, translational and post-translational (including glyco- sylation, phosphorylation and redox) mechanisms and protein-protein inter- action. Egr-1 binds to the DNA sequence 5'-CGCCCCCGC-3' (EGR-site), there- by activating transcription of target genes whose products are required for mitogenisis and differentiation. Egr-2 binds specific DNA sites located in the promoter region of HoxA4. Egr-2 defects cause congenital hypomyelination neuropathy (also designated Charcot-Marie-tooth disease) and Dejerine- Sottas neuropathology (also designated hereditary motor and sensory neuro- pathy III. Egr-3 is involved in muscle spindle development and is expressed in T cells 20 minutes following activation. EGR-4 binds to the EGR consensus motif GCGTGGGCG, functions as a transcriptional repressor, and displays autoregulatory activities, downregulating its on gene promoter in a dose dependent manner.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-110","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3164","replicate":"1","replicate description":"tier 1","original_filename":"GSM803414_hg19_wgEncodeHaibTfbsK562Egr1V0416101RawRep2.bigWig"},"geolst":["GSM803414"]},{"type":"bigWig","name":"Yale ChipSeq K562 IFNa6h","url":"http://egg.wustl.edu/d/hg19/GSM935469_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24650","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNa6h","treatment description":"Interferon alpha treatment - 6 hours (Snyder)","antibody":"STAT2","antibody antibodydescription":"Rabbit polyclonal. Antibody Target: STAT2","antibody targetdescription":"peptide mapping at c-terminus of Human STAT2 p-113 (C-20) X","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-476x","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000656","labversion":"Illumina 2.0, low confidence sequences excluded","replicate":"1","original_filename":"GSM935469_hg19_wgEncodeSydhTfbsK562Stat2Ifna6hStdSig.bigWig"},"geolst":["GSM935469"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 ELF1","url":"http://egg.wustl.edu/d/hg19/GSM803494_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24051","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"ELF1_(SC-631)","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping at the C-terminus of Elf-1 of human origin.","antibody targetdescription":"This gene encodes an E26 transformation-specific related transcription factor.  The encoded protein is primarily expressed in lymphoid cells and acts as both an enhancer and a repressor to regulate transcription of various genes.  Alternative splicing results in multiple transcript variants. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-631","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.2","protocol description":"2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)","controlid":"SL1396","labexpid":"SL2950","replicate":"1","replicate description":"tier 1","original_filename":"GSM803494_hg19_wgEncodeHaibTfbsK562Elf1sc631V0416102RawRep1.bigWig"},"geolst":["GSM803494"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 ELF1","url":"http://egg.wustl.edu/d/hg19/GSM803494_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24051","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"ELF1_(SC-631)","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping at the C-terminus of Elf-1 of human origin.","antibody targetdescription":"This gene encodes an E26 transformation-specific related transcription factor.  The encoded protein is primarily expressed in lymphoid cells and acts as both an enhancer and a repressor to regulate transcription of various genes.  Alternative splicing results in multiple transcript variants. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-631","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.2","protocol description":"2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)","controlid":"SL1396","labexpid":"SL2950","replicate":"1","replicate description":"tier 1","original_filename":"GSM803494_hg19_wgEncodeHaibTfbsK562Elf1sc631V0416102RawRep2.bigWig"},"geolst":["GSM803494"]},{"type":"bigWig","name":"Stanford ChipSeq K562 ZNF384","url":"http://egg.wustl.edu/d/hg19/GSM1003621_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24699","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"ZNF384_(HPA004051)","antibody antibodydescription":"Rabbit polyclonal generated using the immunogen: Zinc finger protein 384 recombinant protein epitope signature tag (PrEST)","antibody targetdescription":"This gene encodes a C2H2-type zinc finger protein, which may function as a transcription factor. This gene also contains long CAG trinucleotide repeats that encode consecutive glutamine residues. The protein appears to bind and regulate the promoters of the extracellular matrix genes MMP1, MMP3, MMP7 and COL1A1. Studies in mouse suggest that nuclear matrix transcription factors (NP/NMP4) may be part of a general mechanical pathway that couples cell construction and function during extracellular matrix remodeling. Alternative splicing results in multiple transcript variants. Recurrent rearrangements of this gene with the Ewing's sarcoma gene, EWSR1 on chromosome 22, or with the TAF15 gene on chromosome 17, or with the TCF3 (E2A) gene on chromosome 19, have been observed in acute leukemia. A related pseudogene has been identified on chromosome 7.","antibody vendorname":"SIGMA","antibody vendorid":"HPA004051","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","labversion":"PeakSeq1.0","original_filename":"GSM1003621_hg19_wgEncodeSydhTfbsK562Znf384hpa004051IggrabSig.bigWig"},"geolst":["GSM1003621"]},{"type":"bigWig","name":"Broad ChipSeq K562 p300","url":"http://egg.wustl.edu/d/hg19/GSM1003583_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24011","30003"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Rabbit Polyclonal. Antibody Target: P300","antibody targetdescription":"EP300(c-20)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-585","controlid":"K562/Input/std","replicate":"1,2","softwareversion":"ScriptureVPaperR3","cell sex":"F","antibody":"p300","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","original_filename":"GSM1003583_hg19_wgEncodeBroadHistoneK562P300StdSig.bigWig"},"geolst":["GSM1003583"]},{"type":"bigWig","name":"Stanford ChipSeq K562 HCFC1","url":"http://egg.wustl.edu/d/hg19/GSM1003625_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24697","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"HCFC1_(NB100-68209)","antibody antibodydescription":"Rabbit polyclonalantibody against residue 1700 and 1750 of human host cell factor C1","antibody targetdescription":"The epitope recognized by this antibody maps to a region between residue 1700 and 1750 of human host cell factor C1 (VP16-accessory protein).","antibody vendorname":"NovusBio","antibody vendorid":"NB100-68209","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","labversion":"PeakSeq1.0","original_filename":"GSM1003625_hg19_wgEncodeSydhTfbsK562Hcfc1nb10068209IggrabSig.bigWig"},"geolst":["GSM1003625"]},{"type":"bigWig","name":"UChicago ChipSeq K562 eGFP-GATA2","url":"http://egg.wustl.edu/d/hg19/GSM777641_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24006","30013"],"details":{"lab":"UChicago","lab description":"White - University of Chicago","data type":"ChipSeq","data type description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"eGFP-GATA2","antibody antibody description":"Goat polyclonal","antibody target description":"GATA2","antibody vendor name":"Kevin White","antibody vendor id":"(None)","control":"Control_eGFP-GATA2","control description":"This data represents a control being compared to experiments using antibody eGFP-GATA2","control id":"K562/Input/Control_eGFP-GATA2","replicate":"1","replicate description":"tier 1","original_filename":"GSM777641_wgEncodeUchicagoTfbsK562Egata2ControlSig.bigWig"},"geolst":["GSM777641"]},{"type":"bigWig","name":"KAP1 K562 ChIP-seq rep2","url":"http://egg.wustl.edu/d/hg19/GSM607492_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24036","30018"],"details":{"cell line":"K562","harvest date":"2010-04-22","chip antibody":"abcam goat anti-KAP1","vendor":"Abcam","catalog#":"ab3831","lot#":"847213","original_filename":"GSM607492_K562_KAP1.bigWIG"},"geolst":["GSM607492"]},{"type":"bigWig","name":"Bernstein K562 CTCF","url":"http://egg.wustl.edu/d/hg19/GSM733719_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24001","30003"],"details":{"cell":"K562","cell organism":"Human","cell description":"leukemia","cell karyotype":"cancer","cell lineage":"The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell sex":"F","antibody":"CTCF","antibody description":"rabbit polyclonal","antibody target description":"CTCF zinc finger transcription factor. A sequence specific DNA binding protein that functions as an insulator, blocking enhancer activity. It has also been suggested to block the spreading of chromatin structure in certain instances.","antibody vendor name":"Millipore","original_filename":"GSM733719_hg19_wgEncodeBroadHistoneK562CtcfStdSig.bigWig"},"geolst":["GSM733719"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 Sin3Ak-20","url":"http://egg.wustl.edu/d/hg19/GSM803525_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24054","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"Sin3Ak-20","antibody antibodydescription":"Rabbit polyclonal, Sin3A (k-20).","antibody targetdescription":"Co-repressor interacting with HDAC1, N-coR, SMRT, and MeCP2","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-994","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3273","replicate":"1","replicate description":"tier 1","original_filename":"GSM803525_hg19_wgEncodeHaibTfbsK562Sin3ak20V0416101RawRep1.bigWig"},"geolst":["GSM803525"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 CREB1","url":"http://egg.wustl.edu/d/hg19/GSM1010890_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24678","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Mouse monoclonal IgG1","antibody targetdescription":"This gene encodes a transcription factor that is a member of the leucine zipper family of DNA binding proteins. This protein binds as a homodimer to the cAMP-responsive element, an octameric palindrome. The protein is phosphorylated by several protein kinases, and induces transcription of genes in response to hormonal stimulation of the cAMP pathway.  Alternate splicing of this gene results in two transcript variants encoding different isoforms. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-240","controlid":"SL12793","labexpid":"SL13293,SL12420","softwareversion":"MACS","cell sex":"F","antibody":"CREB1_(SC-240)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010890_hg19_wgEncodeHaibTfbsK562Creb1sc240V0422111RawRep1.bigWig"},"geolst":["GSM1010890"]},{"type":"bigWig","name":"USC ChipSeq K562 YY1","url":"http://egg.wustl.edu/d/hg19/GSM935368_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24025","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"YY1","antibody antibodydescription":"Rabbit polyclonal. Antibody Target: YY1","antibody targetdescription":"YIN YANG 1 transcription factor belongs to the GLI-Kruppel class of zinc finger proteins.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-1703","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","labversion":"Fragmented using Bioruptor, precipitated with protein G magnetic beads,","replicate":"1","softwareversion":"PeakSeq1.0 (fdr 0.001)","original_filename":"GSM935368_hg19_wgEncodeSydhTfbsK562Yy1UcdSig.bigWig"},"geolst":["GSM935368"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 Max","url":"http://egg.wustl.edu/d/hg19/GSM803523_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24066","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"Max","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping at the C-terminus of Max of human origin.","antibody targetdescription":"The protein encoded by this gene is a member of the basic helix-loop-helix leucine zipper (bHLHZ) family of transcription factors. It is able to form homodimers and heterodimers with other family members, which include Mad, Mxi1 and Myc. Myc is an oncoprotein implicated in cell proliferation, differentiation and apoptosis. The homodimers and heterodimers compete for a common DNA target site (the E box) and rearrangement among these dimer forms provides a complex system of transcriptional regulation. Multiple alternatively spliced transcript variants have been described for this gene but the full-length nature for some of them is unknown (RefSeq).","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-197","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.2","protocol description":"2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)","controlid":"SL1396","labexpid":"SL2945","replicate":"1","replicate description":"tier 1","original_filename":"GSM803523_hg19_wgEncodeHaibTfbsK562MaxV0416102RawRep2.bigWig"},"geolst":["GSM803523"]},{"type":"bigWig","name":"Stanford ChipSeq K562 MafF","url":"http://egg.wustl.edu/d/hg19/GSM935520_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24653","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"MafF_(M8194)","antibody antibodydescription":"Rabbit polyclonal. Raised against synthetic peptide corresponding to amino acids 147-163 of human MAFF. The immunizing peptide does not cross-react with other members of the family. Antibody Target: MafF","antibody targetdescription":"The protein encoded by this gene is a (bZIP) transcription factor that lacks a transactivation domain. It is known to bind the US-2 DNA element in the promoter of the oxytocin receptor (OTR) gene and most likely heterodimerizes with other leucine zipper-containing proteins to enhance expression of the OTR gene during term pregnancy. Can also form homodimers, and since it lacks a transactivation domain, the homodimer may act as a repressor of transcription. May also be involved in the cellular stress response.","antibody vendorname":"Sigma-Aldrich","antibody vendorid":"M8194","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935520_hg19_wgEncodeSydhTfbsK562MaffIggrabSig.bigWig"},"geolst":["GSM935520"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 ETS1","url":"http://egg.wustl.edu/d/hg19/GSM803442_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24057","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"ETS1","antibody antibodydescription":"Rabbit polyclonal IgG","antibody targetdescription":"ETS transcriptions factors, such as ETS1, regulate numerous genes and are involved in stem cell development, cell senescence and death, and tumorigenesis","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-350","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2262","replicate":"1","replicate description":"tier 1","original_filename":"GSM803442_hg19_wgEncodeHaibTfbsK562Ets1V0416101RawRep1.bigWig"},"geolst":["GSM803442"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 ETS1","url":"http://egg.wustl.edu/d/hg19/GSM803442_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24057","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"ETS1","antibody antibodydescription":"Rabbit polyclonal IgG","antibody targetdescription":"ETS transcriptions factors, such as ETS1, regulate numerous genes and are involved in stem cell development, cell senescence and death, and tumorigenesis","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-350","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2262","replicate":"1","replicate description":"tier 1","original_filename":"GSM803442_hg19_wgEncodeHaibTfbsK562Ets1V0416101RawRep2.bigWig"},"geolst":["GSM803442"]},{"type":"bigWig","name":"UChicago ChipSeq K562 eGFP-JunB","url":"http://egg.wustl.edu/d/hg19/GSM777638_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24008","30013"],"details":{"lab":"UChicago","lab description":"White - University of Chicago","data type":"ChipSeq","data type description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"eGFP-JunB","antibody antibody description":"Goat polyclonal","antibody target description":"JunB","antibody vendor name":"Kevin White","antibody vendor id":"(None)","control":"Control_eGFP-JunB","control description":"This data represents a control being compared to experiments using antibody eGFP-JunB","control id":"K562/Input/Control_eGFP-JunB","replicate":"1","replicate description":"tier 1","original_filename":"GSM777638_wgEncodeUchicagoTfbsK562EjunbControlSig.bigWig"},"geolst":["GSM777638"]},{"type":"bigWig","name":"SunyAlbany RipSeq K562 T7Tag","url":"http://egg.wustl.edu/d/hg19/GSM944526_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24074","30021"],"details":{"lab":"SunyAlbany","lab description":"Tenenbaum - SUNY at Albany","datatype":"RipSeq","datatype description":"RNA IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"T7Tag","antibody antibodydescription":"1) Mil AB3790 Anti-t7 Epitope tag, T7 (MASMTGGQQMG) 2) Novagen 69522 Negative Control Ab (T7 Tag Mouse Monoclonal). Antibody Target: T7Tag","antibody targetdescription":"Negative Control Ab (T7 Tag Mouse Monoclonal).","antibody vendorname":"1)Millipore","antibody vendorid":"AB3790","labversion":"Nov_69522 antibody","replicate":"1","original_filename":"GSM944526_hg19_wgEncodeSunyRipSeqK562T7tagSigRep2.bigWig"},"geolst":["GSM944526"]},{"type":"bigWig","name":"SunyAlbany RipSeq K562 PABPC1","url":"http://egg.wustl.edu/d/hg19/GSM944522_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24075","30021"],"details":{"lab":"SunyAlbany","lab description":"Tenenbaum - SUNY at Albany","datatype":"RipSeq","datatype description":"RNA IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"PABPC1","antibody antibodydescription":"Mouse monoclonal vs PABPC1 of human, mouse, bovine, can, hamster, Xenopus origin. Antibody Target: PABPC1","antibody targetdescription":"poly(A) binding protein, cytoplasmic 1 (Homo sapiens).","antibody vendorname":"Sigma Chemical Co.","antibody vendorid":"P6246","labversion":"Sig_P6246 antibody","replicate":"1","original_filename":"GSM944522_hg19_wgEncodeSunyRipSeqK562Pabpc1SigRep2.bigWig"},"geolst":["GSM944522"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 NRSF","url":"http://egg.wustl.edu/d/hg19/GSM803440_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24014","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"NRSF","antibody antibodydescription":"Mouse monoclonal","antibody targetdescription":"Neuron-restrictive silencer transcription factor","antibody vendorname":"David Anderson, Caltech","antibody vendorid":"(Made by Protein Expression Center: pec@caltech.edu)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.2","protocol description":"2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3821","replicate":"1","replicate description":"tier 1","original_filename":"GSM803440_hg19_wgEncodeHaibTfbsK562NrsfV0416102RawRep2.bigWig"},"geolst":["GSM803440"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 NRSF","url":"http://egg.wustl.edu/d/hg19/GSM803440_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24014","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"NRSF","antibody antibodydescription":"Mouse monoclonal","antibody targetdescription":"Neuron-restrictive silencer transcription factor","antibody vendorname":"David Anderson, Caltech","antibody vendorid":"(Made by Protein Expression Center: pec@caltech.edu)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.2","protocol description":"2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3821","replicate":"1","replicate description":"tier 1","original_filename":"GSM803440_hg19_wgEncodeHaibTfbsK562NrsfV0416102RawRep1.bigWig"},"geolst":["GSM803440"]},{"type":"bigWig","name":"Stanford ChipSeq K562 MafK","url":"http://egg.wustl.edu/d/hg19/GSM935311_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24639","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"MafK_(ab50322)","antibody antibodydescription":"Rabbit polyclonal. Raised against synthetic peptide: TTNPKPNKALKVKKEA conjugated to KLH by a C-terminal Cysteine residue linker, corresponding to amino acids 2-17 of Human MAFK. Antibody Target: MafK","antibody targetdescription":"NFE2 DNA-binding activity consists of a heterodimer containing an 18-kD Maf protein (MafF, MafG, or MafK) and p45. Both subunits are members of the activator protein-1 superfamily of basic leucine zipper (bZIP)proteins. Since they lack a putative transactivation domain, small Mafs behave as transcriptional repressors when they dimerize among themselves. They serve as transcriptional activators by dimerizing with other (usually larger) bZip proteins and recruiting them to specific DNA-binding sites.","antibody vendorname":"Abcam","antibody vendorid":"ab50322","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935311_hg19_wgEncodeSydhTfbsK562Mafkab50322IggrabSig.bigWig"},"geolst":["GSM935311"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 CTCFL","url":"http://egg.wustl.edu/d/hg19/GSM803401_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24042","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"CTCFL_(SC-98982)","antibody antibodydescription":"Rabbit polyclonal IgG, epitope corresponding to amino acids 91-210 mapping within an internal region of BORIS(CTCFL) of human origin.","antibody targetdescription":"CCCTC-binding factor (CTCF), an 11-zinc-finger factor involved in gene regulation, utilizes different zinc fingers to bind varying DNA target sites. CTCF forms methylation-sensitive insulators that regulate X-chromosome inactivation.  This gene is a paralog of CTCF and appears to be expressed primarily in the cytoplasm of spermatocytes, unlike CTCF which is expressed primarily in the nucleus of somatic cells.  CTCF and the protein encoded by this gene are normally expressed in a mutually exclusive pattern that correlates with resetting of methylation marks during male germ cell differentiation. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-98982","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3189","replicate":"1","replicate description":"tier 1","original_filename":"GSM803401_hg19_wgEncodeHaibTfbsK562Ctcflsc98982V0416101RawRep2.bigWig"},"geolst":["GSM803401"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 CTCFL","url":"http://egg.wustl.edu/d/hg19/GSM803401_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24042","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"CTCFL_(SC-98982)","antibody antibodydescription":"Rabbit polyclonal IgG, epitope corresponding to amino acids 91-210 mapping within an internal region of BORIS(CTCFL) of human origin.","antibody targetdescription":"CCCTC-binding factor (CTCF), an 11-zinc-finger factor involved in gene regulation, utilizes different zinc fingers to bind varying DNA target sites. CTCF forms methylation-sensitive insulators that regulate X-chromosome inactivation.  This gene is a paralog of CTCF and appears to be expressed primarily in the cytoplasm of spermatocytes, unlike CTCF which is expressed primarily in the nucleus of somatic cells.  CTCF and the protein encoded by this gene are normally expressed in a mutually exclusive pattern that correlates with resetting of methylation marks during male germ cell differentiation. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-98982","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3189","replicate":"1","replicate description":"tier 1","original_filename":"GSM803401_hg19_wgEncodeHaibTfbsK562Ctcflsc98982V0416101RawRep1.bigWig"},"geolst":["GSM803401"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 THAP1","url":"http://egg.wustl.edu/d/hg19/GSM803408_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24047","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"THAP1_(SC-98174)","antibody antibodydescription":"Goat polyclonal IgG, epitope mapping near the C-terminus of THAP1 of human origin.","antibody targetdescription":"The protein encoded by this gene contains a THAP domain, a conserved DNA-binding domain.  This protein colocalizes with the apoptosis response protein PAWR/PAR-4 in promyelocytic leukemia (PML) nuclear bodies, and functions as a proapoptotic factor that links PAWR to PML nuclear bodies.  Alternatively spliced transcript variants encoding distinct isoforms have been observed. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-98174","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2202","replicate":"1","replicate description":"tier 1","original_filename":"GSM803408_hg19_wgEncodeHaibTfbsK562Thap1sc98174V0416101RawRep2.bigWig"},"geolst":["GSM803408"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 THAP1","url":"http://egg.wustl.edu/d/hg19/GSM803408_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24047","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"THAP1_(SC-98174)","antibody antibodydescription":"Goat polyclonal IgG, epitope mapping near the C-terminus of THAP1 of human origin.","antibody targetdescription":"The protein encoded by this gene contains a THAP domain, a conserved DNA-binding domain.  This protein colocalizes with the apoptosis response protein PAWR/PAR-4 in promyelocytic leukemia (PML) nuclear bodies, and functions as a proapoptotic factor that links PAWR to PML nuclear bodies.  Alternatively spliced transcript variants encoding distinct isoforms have been observed. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-98174","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2202","replicate":"1","replicate description":"tier 1","original_filename":"GSM803408_hg19_wgEncodeHaibTfbsK562Thap1sc98174V0416101RawRep1.bigWig"},"geolst":["GSM803408"]},{"type":"bigWig","name":"Yale ChipSeq K562 Rad21","url":"http://egg.wustl.edu/d/hg19/GSM935319_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24052","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Rad21","antibody antibodydescription":"Rabbit polyclonal. Antibody Target: RAD21","antibody targetdescription":"Synthetic peptide (Human) conjugated to KLH - which represents a portion of human Rad21 encoded within exon 14","antibody vendorname":"Abcam","antibody vendorid":"ab992","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","labversion":"Contains incomplete fastq files","replicate":"1","original_filename":"GSM935319_hg19_wgEncodeSydhTfbsK562Rad21StdSig.bigWig"},"geolst":["GSM935319"]},{"type":"bigWig","name":"Stanford ChipSeq K562 Nrf1","url":"http://egg.wustl.edu/d/hg19/GSM935361_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24635","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Nrf1","antibody antibodydescription":"Mouse monoclonal, Immunogen corresponding to amino acids 201-286 of Human NRF1. Antibody Target: NRF1","antibody targetdescription":"NRF1 is the mammalian homolog to the erect wing (ewg) Drosophila protein that is required for proper development of the central nervous system and indirect flight muscles. In mammals NRF1 functions as a transcription factor that activates the expression of the EIF2S1 (EIF-alpha) gene. This protein links the transcriptional modulation of key metabolic genes to cellular growth and development, and has been implicated in the control of nuclear genes required for respiration, heme biosynthesis and mitochondrialDNA transcription and replication. NRF1 forms a homodimer and binds DNA as a dimer. NRF1 shows a nuclear localization and is expressed widely in embryonic, fetal and adult tissues. Phosphorylation of NRF1 enhances DNA binding.","antibody vendorname":"Abcam","antibody vendorid":"ab55744","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935361_hg19_wgEncodeSydhTfbsK562Nrf1IggrabSig.bigWig"},"geolst":["GSM935361"]},{"type":"bigWig","name":"Stanford ChipSeq K562 USF2","url":"http://egg.wustl.edu/d/hg19/GSM935356_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24627","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"USF2","antibody antibodydescription":"Mouse monoclonal. Immunogen corresponds to amino acids 1-101 of Human USF2. Antibody Target: USF2","antibody targetdescription":"Encodes a member of the basic helix-loop-helix leucine zipper family. The encoded protein can activate transcription through pyrimidine-rich initiator (Inr) elements and E-box motifs (5'-CACGTG-3').","antibody vendorname":"abcam","antibody vendorid":"ab60931","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935356_hg19_wgEncodeSydhTfbsK562Usf2IggrabSig.bigWig"},"geolst":["GSM935356"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 RevXlinkChromatin","url":"http://egg.wustl.edu/d/hg19/GSM1010894_3.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24017","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","controlid":"SL12793,SL6023,SL11659,SL9103","labexpid":"SL12793,SL6023,SL11659,SL9103","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"RevXlinkChromatin","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,3,2,4","original_filename":"GSM1010894_hg19_wgEncodeHaibTfbsK562RxlchV0422111RawRep3.bigWig"},"geolst":["GSM1010894"]},{"type":"bigWig","name":"Yale ChipSeq K562 Pol2","url":"http://egg.wustl.edu/d/hg19/GSM935358_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24003","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Pol2","antibody antibodydescription":"mouse monoclonal, clone 8WG16. Antibody Target: POL2","antibody targetdescription":"RNA Polymerase II","antibody vendorname":"Covance","antibody vendorid":"MMS-126R","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","replicate":"1","original_filename":"GSM935358_hg19_wgEncodeSydhTfbsK562Pol2StdSig.bigWig"},"geolst":["GSM935358"]},{"type":"bigWig","name":"Stanford ChipSeq K562 COREST","url":"http://egg.wustl.edu/d/hg19/GSM935439_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24617","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"COREST_(sc-30189)","antibody antibodydescription":"Rabbit polyclonal, epitope corresponding to amino acids 246-310 mapping within an internal region of CoREST of human origin recommended for detection of CoREST of mouse, rat and human origin. Antibody Target: COREST (sc30189)","antibody targetdescription":"Essential component of the BHC complex, a corepressor complex that represses transcription of neuron-specific genes in non-neuronal cells.  In the BHC complex, it serves as a molecular beacon for the recruitment of molecular machinery, including MeCP2 and SUV39H1, that imposes silencing across a chromosomal interval. Plays a central role in demethylation of Lys-4 of histone H3 by promoting demethylase activity of KDM1A on core histones and nucleosomal substrates.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-30189","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935439_hg19_wgEncodeSydhTfbsK562Corestsc30189IggrabSig.bigWig"},"geolst":["GSM935439"]},{"type":"bigWig","name":"Stanford ChipSeq K562 NF-YA","url":"http://egg.wustl.edu/d/hg19/GSM935433_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24649","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"NF-YA","antibody antibodydescription":"Affinity purified rabbit polyclonal raised against amino acids 139-347 of recombinant human NF-YA. Antibody Target: NF-YA","antibody targetdescription":"NF-YA is the alpha subunit of the trimeric NFY transcription factor complex that binds to the ubiquitous CCAAT motif","antibody vendorname":"Donated by Dr. R. Mantovani, Universita degli Studi di Milano, Italy","antibody vendorid":"missing","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","replicate":"1","original_filename":"GSM935433_hg19_wgEncodeSydhTfbsK562NfyaStdSig.bigWig"},"geolst":["GSM935433"]},{"type":"bigWig","name":"Stanford ChipSeq K562 Pol2(phosphoS2)","url":"http://egg.wustl.edu/d/hg19/GSM935402_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24634","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Pol2(phosphoS2)","antibody antibodydescription":"Rabbit polyclonal against peptide conjugated to KLH derived from within residues 1600 - 1700 of S. cerevisiae RNA polymerase II CTD repeat YSPTSPS, phosphorylated at S2. Antibody Target: POL2S2","antibody targetdescription":"RNA polymerase II, large subunit- specific for phosphorylated C-terminal domain.","antibody vendorname":"Abcam","antibody vendorid":"ab5095","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935402_hg19_wgEncodeSydhTfbsK562Pol2s2IggrabSig.bigWig"},"geolst":["GSM935402"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 PML","url":"http://egg.wustl.edu/d/hg19/GSM1010722_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24688","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Mouse monoclonal IgG, N-terminal epitope corresponding to residues 37-51 of PML of human origin. Antibody Target: PML","antibody targetdescription":"The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. This phosphoprotein localizes to nuclear bodies where it functions as a transcription factor and tumor suppressor. Its expression is cell-cycle related and it regulates the p53 response to oncogenic signals. The gene is often involved in the translocation with the retinoic acid receptor alpha gene associated with acute promyelocytic leukemia (APL). Extensive alternative splicing of this gene results in several variations of the protein's central and C-terminal regions","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-71910","controlid":"SL6023","labexpid":"SL7894,SL8137","softwareversion":"MACS","cell sex":"F","antibody":"PML_(SC-71910)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010722_hg19_wgEncodeHaibTfbsK562Pmlsc71910V0422111RawRep1.bigWig"},"geolst":["GSM1010722"]},{"type":"bigWig","name":"Stanford ChipSeq K562 JunD","url":"http://egg.wustl.edu/d/hg19/GSM935569_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24063","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"JunD","antibody antibodydescription":"rabbit polyclonal IgG. Antibody Target: JunD","antibody targetdescription":"The protein encoded by this intronless gene is a member of the JUN family, and a functional component of the AP1 transcription factor complex. It has been proposed to protect cells from p53-dependent senescence and apoptosis. Alternate translation initiation site usage results in the production of different isoforms. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-74","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935569_hg19_wgEncodeSydhTfbsK562JundIggrabSig.bigWig"},"geolst":["GSM935569"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 PML","url":"http://egg.wustl.edu/d/hg19/GSM1010722_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24688","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Mouse monoclonal IgG, N-terminal epitope corresponding to residues 37-51 of PML of human origin. Antibody Target: PML","antibody targetdescription":"The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. This phosphoprotein localizes to nuclear bodies where it functions as a transcription factor and tumor suppressor. Its expression is cell-cycle related and it regulates the p53 response to oncogenic signals. The gene is often involved in the translocation with the retinoic acid receptor alpha gene associated with acute promyelocytic leukemia (APL). Extensive alternative splicing of this gene results in several variations of the protein's central and C-terminal regions","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-71910","controlid":"SL6023","labexpid":"SL7894,SL8137","softwareversion":"MACS","cell sex":"F","antibody":"PML_(SC-71910)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010722_hg19_wgEncodeHaibTfbsK562Pmlsc71910V0422111RawRep2.bigWig"},"geolst":["GSM1010722"]},{"type":"bigWig","name":"Stanford ChipSeq K562 RFX5","url":"http://egg.wustl.edu/d/hg19/GSM935565_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24605","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"RFX5_(200-401-194)","antibody antibodydescription":"Rabbit polyclonal against RFX5 peptide corresponding to a region at amino acids 320 to 494 of the human protein conjugated to Keyhole Limpet Hemocyanin. Antibody Target: RFX5","antibody targetdescription":"Activates transcription from class II MHC promoters. Recognizes X-boxes. Mediates cooperative binding betweenRFX and NF-Y. RFX binds the X1 box of MHC-II promoters","antibody vendorname":"Rockland Immunochemicals","antibody vendorid":"200-401-194","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935565_hg19_wgEncodeSydhTfbsK562Rfx5IggrabSig.bigWig"},"geolst":["GSM935565"]},{"type":"bigWig","name":"USC ChipSeq K562 TR4","url":"http://egg.wustl.edu/d/hg19/GSM935374_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24644","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"TR4","antibody antibodydescription":"Rabbit polyclonal. Antibody Target: TR4","antibody targetdescription":"(Also: NR2C2) Members of the nuclear hormone receptor family, such as NR2C2, act as ligand-activated transcription factors. The proteins have an N-terminal transactivation domain, a central DNA-binding domain with 2 zinc fingers, and a ligand-binding domain at the C terminus.","antibody vendorname":"Donated by Dr. J.D.Engel, University of Michigan","antibody vendorid":"TR4","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","labversion":"Fragmented using Bioruptor, precipitated with protein A agarose beads,","replicate":"1","softwareversion":"PeakSeq1.0 (fdr 0.001)","original_filename":"GSM935374_hg19_wgEncodeSydhTfbsK562Tr4UcdSig.bigWig"},"geolst":["GSM935374"]},{"type":"bigWig","name":"Harvard ChipSeq K562 BRF1","url":"http://egg.wustl.edu/d/hg19/GSM935595_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24668","30020"],"details":{"lab":"Harvard","lab description":"Struhl - Harvard University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"BRF1","antibody antibodydescription":"Rabbit polyclonal - Anti-BRF antibody 128 was raised by immunising rabbits with synthetic peptide KISSKINYSVLRGLS (human BRF residues 533-547) coupled to keyhole limpet haemocyanin. Antibody Target: BRF1","antibody targetdescription":"'B-related factor 1', subunit of RNA polymerase III transcription initiation factor IIIB","antibody vendorname":"Donated by Dr. RJ White, The Beatson Institute for Cancer Research","antibody vendorid":"128","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","labversion":"Illumina 2.0, low confidence sequences excluded, fragmented with both a probe sonicator and a Misonix sonicator, and precipitated with protein A sepharose beads","replicate":"1","original_filename":"GSM935595_hg19_wgEncodeSydhTfbsK562Brf1StdSig.bigWig"},"geolst":["GSM935595"]},{"type":"bigWig","name":"Stanford ChipSeq K562 Znf143","url":"http://egg.wustl.edu/d/hg19/GSM935568_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24616","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Znf143_(16618-1-AP)","antibody antibodydescription":"Rabbit polyclonal against human ZNF143 (amino acids 283-626)-6his fusion protein. Antibody Target: Znf143","antibody targetdescription":"Transcriptional activator. Activates the gene for selenocysteine tRNA (tRNAsec). Binds to the SPH motif of small nuclear RNA (snRNA) gene promoters. Participates to efficient U6 RNA polymerase III transcription via its interaction with CHD8","antibody vendorname":"Proteintech","antibody vendorid":"16618-1-AP","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935568_hg19_wgEncodeSydhTfbsK562Znf143IggrabSig.bigWig"},"geolst":["GSM935568"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 YY1","url":"http://egg.wustl.edu/d/hg19/GSM803470_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24025","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"YY1","antibody antibodydescription":"Rabbit polyclonal","antibody targetdescription":"YIN YANG 1 transcription factor belongs to the GLI-Kruppel class of zinc finger proteins.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-1703","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.2","protocol description":"2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)","controlid":"SL1396","labexpid":"SL2946","replicate":"1","replicate description":"tier 1","original_filename":"GSM803470_hg19_wgEncodeHaibTfbsK562Yy1V0416102RawRep2.bigWig"},"geolst":["GSM803470"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 YY1","url":"http://egg.wustl.edu/d/hg19/GSM803470_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24025","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"YY1","antibody antibodydescription":"Rabbit polyclonal","antibody targetdescription":"YIN YANG 1 transcription factor belongs to the GLI-Kruppel class of zinc finger proteins.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-1703","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.2","protocol description":"2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)","controlid":"SL1396","labexpid":"SL2946","replicate":"1","replicate description":"tier 1","original_filename":"GSM803470_hg19_wgEncodeHaibTfbsK562Yy1V0416102RawRep1.bigWig"},"geolst":["GSM803470"]},{"type":"bigWig","name":"USC ChipSeq K562 GATA-2","url":"http://egg.wustl.edu/d/hg19/GSM935373_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24642","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"GATA-2","antibody antibodydescription":"Rabbit polyclonal. Antibody Target: GATA2","antibody targetdescription":"GATA binding protein 2","antibody vendorname":"Donated by Dr. E.H. Bresnick, UW Madison","antibody vendorid":"GATA-2","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","labversion":"Fragmented using Bioruptor, precipitated with StaphA","replicate":"1","softwareversion":"PeakSeq1.0 (fdr 0.001)","original_filename":"GSM935373_hg19_wgEncodeSydhTfbsK562Gata2UcdSig.bigWig"},"geolst":["GSM935373"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 ZBTB7A","url":"http://egg.wustl.edu/d/hg19/GSM803473_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24061","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"ZBTB7A_(SC-34508)","antibody antibodydescription":"Goat polyclonal IgG, epitope mapping at the C-terminus of LRF of human origin.","antibody targetdescription":"Plays a key role in the instruction of early lymphoid progenitors to develop into B lineage by repressing T-cell instructive Notch signals (By similarity).","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-34508","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2265","replicate":"1","replicate description":"tier 1","original_filename":"GSM803473_hg19_wgEncodeHaibTfbsK562Zbtb7asc34508V0416101RawRep1.bigWig"},"geolst":["GSM803473"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 ZBTB7A","url":"http://egg.wustl.edu/d/hg19/GSM803473_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24061","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"ZBTB7A_(SC-34508)","antibody antibodydescription":"Goat polyclonal IgG, epitope mapping at the C-terminus of LRF of human origin.","antibody targetdescription":"Plays a key role in the instruction of early lymphoid progenitors to develop into B lineage by repressing T-cell instructive Notch signals (By similarity).","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-34508","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2265","replicate":"1","replicate description":"tier 1","original_filename":"GSM803473_hg19_wgEncodeHaibTfbsK562Zbtb7asc34508V0416101RawRep2.bigWig"},"geolst":["GSM803473"]},{"type":"bigWig","name":"Stanford ChipSeq K562 CHD2","url":"http://egg.wustl.edu/d/hg19/GSM935502_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24606","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"CHD2_(AB68301)","antibody antibodydescription":"Rabbit polyclonal to CHD2 Synthetic peptide derived from within residues 1250 - 1350 of Human CHD2. Antibody Target: CHD2","antibody targetdescription":"CHD family of proteins are characterized by presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template.","antibody vendorname":"Abcam","antibody vendorid":"ab68301","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935502_hg19_wgEncodeSydhTfbsK562Chd2ab68301IggrabSig.bigWig"},"geolst":["GSM935502"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 HEY1","url":"http://egg.wustl.edu/d/hg19/GSM803385_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24034","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"HEY1","antibody antibodydescription":"HRT1 (C-20) Goat polyclonal IgG, 200 ?g/ml. Epitope mapping near the C-terminus of HRT1 of human origin","antibody targetdescription":"This gene encodes a nuclear protein belonging to the hairy and enhancer of split-related (HESR) family of basic helix-loop-helix (bHLH)-type transcriptional repressors. Expression of this gene is induced by the Notch and c-Jun signal transduction pathways. Two similar and redundant genes in mouse are required for embryonic cardiovascular development, and are also implicated in neurogenesis and somitogenesis. Alternative splicing results in multiple transcript variants.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-16424","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL518","labexpid":"SL845","replicate":"1","replicate description":"tier 1","original_filename":"GSM803385_hg19_wgEncodeHaibTfbsK562Hey1Pcr1xRawRep1.bigWig"},"geolst":["GSM803385"]},{"type":"bigWig","name":"Stanford ChipSeq K562 NF-YB","url":"http://egg.wustl.edu/d/hg19/GSM935429_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24615","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"NF-YB","antibody antibodydescription":"Affinity purified rabbit polyclonal raised against recombinant full length human NF-YB. Antibody Target: NF-YB","antibody targetdescription":"NF-YB is the beta subunit of the trimeric NFY transcription factor complex that binds to the ubiquitous CCAAT motif","antibody vendorname":"Donated by Dr. R. Mantovani, Universita degli Studi di Milano, Italy","antibody vendorid":"missing","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","replicate":"1","original_filename":"GSM935429_hg19_wgEncodeSydhTfbsK562NfybStdSig.bigWig"},"geolst":["GSM935429"]},{"type":"bigWig","name":"Yale ChipSeq K562 XRCC4","url":"http://egg.wustl.edu/d/hg19/GSM935425_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24673","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"XRCC4","antibody antibodydescription":"Rabbit polyclonal. Antibody Target: XRCC4","antibody targetdescription":"Recognizes the XRCC4 protein (X ray cross complementation protein). XRCC4 is a ubiquitous protein reported to have a role in DNA double-stranded break repair and in V(D)J recombination.","antibody vendorname":"Abcam","antibody vendorid":"ab145","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","labversion":"Contains incomplete fastq files","replicate":"1","original_filename":"GSM935425_hg19_wgEncodeSydhTfbsK562Xrcc4StdSig.bigWig"},"geolst":["GSM935425"]},{"type":"bigWig","name":"UT-A ChipSeq K562 c-Myc","url":"http://egg.wustl.edu/d/hg19/GSM822310_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24004","30009"],"details":{"lab":"UT-A","lab description":"Iyer - University of Texas at Austin","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"c-Myc","antibody antibodydescription":"rabbit polyclonal to amino acids 1-262 of c-Myc human origin","antibody targetdescription":"transcription factor","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-764","controlid":"K562/Input","labversion":"align_on_cluster_bwa.pl v 1","replicate":"1","replicate description":"tier 1","original_filename":"GSM822310_hg19_wgEncodeOpenChromChipK562CmycSig.bigWig"},"geolst":["GSM822310"]},{"type":"bigWig","name":"UT-A ChipSeq K562 c-Myc","url":"http://egg.wustl.edu/d/hg19/GSM822310_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24004","30009"],"details":{"lab":"UT-A","lab description":"Iyer - University of Texas at Austin","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"c-Myc","antibody antibodydescription":"rabbit polyclonal to amino acids 1-262 of c-Myc human origin","antibody targetdescription":"transcription factor","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-764","controlid":"K562/Input","labversion":"align_on_cluster_bwa.pl v 1","replicate":"1","replicate description":"tier 1","original_filename":"GSM822310_hg19_wgEncodeOpenChromChipK562CmycBaseOverlapSignal.bigWig"},"geolst":["GSM822310"]},{"type":"bigWig","name":"Stanford ChipSeq K562 IFNg30","url":"http://egg.wustl.edu/d/hg19/GSM935388_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24003","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNg30","treatment description":"Interferon gamma treatment - 30 minutes (Snyder)","antibody":"Pol2","antibody antibodydescription":"mouse monoclonal, clone 8WG16. Antibody Target: POL2","antibody targetdescription":"RNA Polymerase II","antibody vendorname":"Covance","antibody vendorid":"MMS-126R","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000657","replicate":"1","original_filename":"GSM935388_hg19_wgEncodeSydhTfbsK562Pol2Ifng30StdSig.bigWig"},"geolst":["GSM935388"]},{"type":"bigWig","name":"Yale ChipSeq K562 IFNa6h","url":"http://egg.wustl.edu/d/hg19/GSM935474_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24003","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNa6h","treatment description":"Interferon alpha treatment - 6 hours (Snyder)","antibody":"Pol2","antibody antibodydescription":"mouse monoclonal, clone 8WG16. Antibody Target: POL2","antibody targetdescription":"RNA Polymerase II","antibody vendorname":"Covance","antibody vendorid":"MMS-126R","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000656","replicate":"1","original_filename":"GSM935474_hg19_wgEncodeSydhTfbsK562Pol2Ifna6hStdSig.bigWig"},"geolst":["GSM935474"]},{"type":"bigWig","name":"Yale ChipSeq K562 IFNa30","url":"http://egg.wustl.edu/d/hg19/GSM935472_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24620","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNa30","treatment description":"30 m of Interferon alpha (Snyder)","antibody":"STAT1","antibody antibodydescription":"rabbit polyclonal to STAT1 (alpha) p-91 (C-24). Antibody Target: STAT1","antibody targetdescription":"transcription factor, activated by interferon signalling","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-345","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000655","labversion":"Illumina 2.0, low confidence sequences excluded","replicate":"1","original_filename":"GSM935472_hg19_wgEncodeSydhTfbsK562Stat1Ifna30StdSig.bigWig"},"geolst":["GSM935472"]},{"type":"bigWig","name":"USC ChipSeq K562 MNaseD","url":"http://egg.wustl.edu/d/hg19/GSM935573_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24619","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"MNaseD","treatment description":"Fragmented using micrococcal nuclease digestion","antibody":"SETDB1","antibody antibodydescription":"Rabbit polyclonal. Antibody Target: SETDB1","antibody targetdescription":"SET domain, bifurcated 1, the SET domain is a highly conserved, approximately 150-amino acid motif implicated in the modulation of chromatin structure","antibody vendorname":"Proteintech Group","antibody vendorid":"11231-1-AP","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","labversion":"remapped from hg18, Fragmented using MNase and used proteinA agarose beads for ChIPs, PeakSeq 1.0 (fdr 0.001)","replicate":"1","original_filename":"GSM935573_hg19_wgEncodeSydhTfbsK562Setdb1MnasedUcdSig.bigWig"},"geolst":["GSM935573"]},{"type":"bigWig","name":"UChicago ChipSeq K562 eGFP-FOS","url":"http://egg.wustl.edu/d/hg19/GSM777644_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24005","30013"],"details":{"lab":"UChicago","lab description":"White - University of Chicago","data type":"ChipSeq","data type description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"eGFP-FOS","antibody antibody description":"Goat polyclonal","antibody target description":"Fos","antibody vendor name":"Kevin White","antibody vendor id":"(None)","control":"Control_eGFP-FOS","control description":"This data represents a control being compared to experiments using antibody eGFP-FOS","control id":"K562/Input/Control_eGFP-FOS","replicate":"1","replicate description":"tier 1","original_filename":"GSM777644_wgEncodeUchicagoTfbsK562EfosControlSig.bigWig"},"geolst":["GSM777644"]},{"type":"bigWig","name":"Broad ChipSeq K562 CBX3","url":"http://egg.wustl.edu/d/hg19/GSM1003568_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24685","30003"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Mouse monoclonal IgG, raised against recombinant CBX3 of human origin. Antibody Target: CBX3","antibody targetdescription":"At the nuclear envelope, the nuclear lamina and heterochromatin are adjacent to the inner nuclear membrane. The protein encoded by this gene binds DNA and is a component of heterochromatin. This protein also can bind lamin B receptor, an integral membrane protein found in the inner nuclear membrane. The dual binding functions of the encoded protein may explain the association of heterochromatin with the inner nuclear membrane. This protein binds histone H3 tails methylated at Lys-9 sites. This protein is also recruited to sites of ultraviolet-induced DNA damage and double-strand breaks. Two transcript variants encoding the same protein but differing in the 5' UTR, have been found for this gene.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-101004","controlid":"K562/None/Input/std","replicate":"1","softwareversion":"ScriptureVPaperR3","cell sex":"F","antibody":"CBX3_(SC-101004)","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","labversion":"Illumina_GA2x","labversion description":"Illumina Genome Analyzer IIx","original_filename":"GSM1003568_hg19_wgEncodeBroadHistoneK562Cbx3sc101004Sig.bigWig"},"geolst":["GSM1003568"]},{"type":"bigWig","name":"Stanford ChipSeq K562 IFNg30","url":"http://egg.wustl.edu/d/hg19/GSM935505_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24652","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNg30","treatment description":"Interferon gamma treatment - 30 minutes (Snyder)","antibody":"IRF1","antibody antibodydescription":"IRF-1 (C-20) is an affinity purified rabbit polyclonal antibody raised against a peptide mapping at the C-terminus of IRF-1 of human origin. Antibody Target: IRF1","antibody targetdescription":"Interferon regulatory factor 1 is a member of the interferon regulatory transcription factor (IRF) family. IRF1 serves as an activator of interferons alpha and beta transcription and also functions as a transcription activator of genes induced by interferons alpha, beta, and gamma. IRF1 has been shown to play roles in regulating apoptosis and tumor suppression.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-497","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000657","replicate":"1","original_filename":"GSM935505_hg19_wgEncodeSydhTfbsK562Irf1Ifng30StdSig.bigWig"},"geolst":["GSM935505"]},{"type":"bigWig","name":"Stanford ChipSeq K562 TBLR1","url":"http://egg.wustl.edu/d/hg19/GSM935575_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24628","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"TBLR1_(ab24550)","antibody antibodydescription":"Rabbit polyclonal, immunogen: Recombinant full length protein (Human). Antibody Target: TBLR1","antibody targetdescription":"F-box-like protein involved in the recruitment of the ubiquitin/19S proteasome complex to nuclear receptor-regulated transcription units. Plays an essential role in transcription activation mediated by nuclear receptors. Probably acts as integral component of the N-Cor corepressor complex that mediates the recruitment of the 19S proteasome complex, leading to the subsequent proteasomal degradation of N-Cor complex, thereby allowing cofactor exchange, and transcription activation","antibody vendorname":"Abcam","antibody vendorid":"ab24550","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935575_hg19_wgEncodeSydhTfbsK562Tblr1ab24550IggrabSig.bigWig"},"geolst":["GSM935575"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 CTCF","url":"http://egg.wustl.edu/d/hg19/GSM1010820_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24001","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Goat polyclonal IgG, epitope mapping at the N-terminus of CTCF of human origin. Antibody Target: CTCF","antibody targetdescription":"This gene is a member of the BORIS + CTCF gene family and encodes a transcriptional regulator protein with 11 highly conserved zinc finger (ZF) domains. This nuclear protein is able to use different combinations of the ZF domains to bind different DNA target sequences and proteins. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-5916","controlid":"SL1396,SL1397","labexpid":"SL3075,SL5605","softwareversion":"MACS","cell sex":"F","antibody":"CTCF_(SC-5916)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"one 15-cycle round of PCR (Myers)","replicate":"1,2","original_filename":"GSM1010820_hg19_wgEncodeHaibTfbsK562CtcfcPcr1xRawRep1V2.bigWig"},"geolst":["GSM1010820"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 GATA2","url":"http://egg.wustl.edu/d/hg19/GSM803540_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24069","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"GATA2_(SC-267)","antibody antibodydescription":"Mouse monoclonal IgG.","antibody targetdescription":"This gene encodes a member of the GATA family of zinc-finger transcription factors that are named for the consensus nucleotide sequence they bind in the promoter regions of target genes. The encoded program plays an essential role in regulation transcription of genes involved in the development and proliferation of hematopoietic and endocrine cell lineages (RefSeq).","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-267","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL2455","labexpid":"SL1430","replicate":"1","replicate description":"tier 1","original_filename":"GSM803540_hg19_wgEncodeHaibTfbsK562Gata2sc267Pcr1xRawRep2.bigWig"},"geolst":["GSM803540"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 GATA2","url":"http://egg.wustl.edu/d/hg19/GSM803540_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24069","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"GATA2_(SC-267)","antibody antibodydescription":"Mouse monoclonal IgG.","antibody targetdescription":"This gene encodes a member of the GATA family of zinc-finger transcription factors that are named for the consensus nucleotide sequence they bind in the promoter regions of target genes. The encoded program plays an essential role in regulation transcription of genes involved in the development and proliferation of hematopoietic and endocrine cell lineages (RefSeq).","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-267","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL2455","labexpid":"SL1430","replicate":"1","replicate description":"tier 1","original_filename":"GSM803540_hg19_wgEncodeHaibTfbsK562Gata2sc267Pcr1xRawRep1.bigWig"},"geolst":["GSM803540"]},{"type":"bigWig","name":"Stanford ChipSeq K562 COREST","url":"http://egg.wustl.edu/d/hg19/GSM935385_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24617","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"COREST_(ab24166)","antibody antibodydescription":"Synthetic peptide conjugated to KLH derived from within residues 400 to the C-terminus of Human CoREST.   Note: This antibody has since been discontinued.  Full product information is attached as part of validation document. Antibody Target: COREST_(ab24166)","antibody targetdescription":"Essential component of the BHC complex, a corepressor complex that represses transcription of neuron-specific genes in non-neuronal cells.  In the BHC complex, it serves as a molecular beacon for the recruitment of molecular machinery, including MeCP2 and SUV39H1, that imposes silencing across a chromosomal interval. Plays a central role in demethylation of Lys-4 of histone H3 by promoting demethylase activity of KDM1A on core histones and nucleosomal substrates.","antibody vendorname":"Abcam","antibody vendorid":"ab24166","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935385_hg19_wgEncodeSydhTfbsK562Corestab24166IggrabSig.bigWig"},"geolst":["GSM935385"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 ZBTB33","url":"http://egg.wustl.edu/d/hg19/GSM803504_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24039","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"ZBTB33","antibody antibodydescription":"Kaiso (6F8) Mouse monoclonal IgG1. Raised against amino acids 1-504 representing full length Kaiso of human origin. Recommended for detection of Kaiso of m, r, h, canine and chicken origin by WB, IP, IF and ELISA","antibody targetdescription":"KAISO is a transcriptional regulator that binds, via its zinc fingers, to DNA sequences containing methylated CGCG or to the consensus KAISO-binding site (KBS) TCCTGCNA","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-23871","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL2455","labexpid":"SL1114","replicate":"1","replicate description":"tier 1","original_filename":"GSM803504_hg19_wgEncodeHaibTfbsK562Zbtb33Pcr1xRawRep2.bigWig"},"geolst":["GSM803504"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 ZBTB33","url":"http://egg.wustl.edu/d/hg19/GSM803504_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24039","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"ZBTB33","antibody antibodydescription":"Kaiso (6F8) Mouse monoclonal IgG1. Raised against amino acids 1-504 representing full length Kaiso of human origin. Recommended for detection of Kaiso of m, r, h, canine and chicken origin by WB, IP, IF and ELISA","antibody targetdescription":"KAISO is a transcriptional regulator that binds, via its zinc fingers, to DNA sequences containing methylated CGCG or to the consensus KAISO-binding site (KBS) TCCTGCNA","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-23871","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL2455","labexpid":"SL1114","replicate":"1","replicate description":"tier 1","original_filename":"GSM803504_hg19_wgEncodeHaibTfbsK562Zbtb33Pcr1xRawRep1.bigWig"},"geolst":["GSM803504"]},{"type":"bigWig","name":"USC ChipSeq K562 ZNF274","url":"http://egg.wustl.edu/d/hg19/GSM935479_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24070","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"ZNF274","antibody antibodydescription":"Mouse polyclonal antibody raised against a partial recombinant ZNF274 (GST-fusion of a.a.420-531 of human ZNF274 protein). Works in IP, WB and ELISA. Antibody Target: ZNF274","antibody targetdescription":"ZNF274 is a zinc finger protein containing five C2H2-type zinc finger domains, two Kruppel-associated box A (KRABA) domains, and a leucine-rich SCAN domain. The encoded protein has been suggested to be a transcriptional repressor. It localizes predominantly to the nucleolus.","antibody vendorname":"ABNOVA","antibody vendorid":"H00010782-A01","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","labversion":"Fragmented using Bioruptor, precipitated with StaphA","replicate":"1","softwareversion":"PeakSeq1.0 (fdr 0.001)","original_filename":"GSM935479_hg19_wgEncodeSydhTfbsK562Znf274UcdSig.bigWig"},"geolst":["GSM935479"]},{"type":"bigWig","name":"Stanford ChipSeq K562 ZNF-MIZD-CP1","url":"http://egg.wustl.edu/d/hg19/GSM1003611_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24701","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"ZNF-MIZD-CP1_(ab65767)","antibody antibodydescription":"Rabbit Polyclonal against synthetic peptide conjugated to KLH derived from within residues 200 - 300 of Human Zinc finger MIZ domain-containing protein 1.","antibody targetdescription":"Zinc finger MIZ domain-containing protein 1 that increases ligand-dependent transcriptional activity of AR and promotes AR sumoylation. The stimulation of AR activity is dependent upon sumoylation.","antibody vendorname":"Abcam","antibody vendorid":"ab65767","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","labversion":"PeakSeq1.0","original_filename":"GSM1003611_hg19_wgEncodeSydhTfbsK562Znfmizdcp1ab65767IggrabSig.bigWig"},"geolst":["GSM1003611"]},{"type":"bigWig","name":"Stanford ChipSeq K562 ELK1","url":"http://egg.wustl.edu/d/hg19/GSM1003620_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24671","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"ELK1_(1277-1)","antibody antibodydescription":"Rabbit polyclonal, a synthetic peptide corresponding to residues in C-terminus of human ELK-1 was used as immunogen. The antibody does not cross-react with other ETS family members. Antibody Target: ELK1","antibody targetdescription":"Elk-1 is a transcription factor that is part of the ets oncogene superfamily. Elk-1 forms a ternary complex with the serum response factors, SRE and SRF, mediating gene activity in response to serum and growth factors. Activation by several mitogen- activated protein kinases (Erk1 and Erk2) mediates the immediate early responses of the c-fos promoter to growth factors and other stimuli.","antibody vendorname":"Epitomics","antibody vendorid":"1277-1","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","labversion":"PeakSeq1.0","original_filename":"GSM1003620_hg19_wgEncodeSydhTfbsK562Elk112771IggrabSig.bigWig"},"geolst":["GSM1003620"]},{"type":"bigWig","name":"Stanford ChipSeq K562 BHLHE40","url":"http://egg.wustl.edu/d/hg19/GSM935616_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24062","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"BHLHE40_(NB100-1800)","antibody antibodydescription":"Rabbit polyclonal, maps to a region between residues 350 and the C-terminus (residue 412). Antibody Target: BHLHE40","antibody targetdescription":"This gene encodes a basic helix-loop-helix protein expressed in various tissues. Expression in the chondrocytes is responsive to the addition of Bt2cAMP. The encoded protein is believed to be involved in the control of cell differentiation.","antibody vendorname":"Novus","antibody vendorid":"NB100-1800","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935616_hg19_wgEncodeSydhTfbsK562Bhlhe40nb100IggrabSig.bigWig"},"geolst":["GSM935616"]},{"type":"bigWig","name":"Yale ChipSeq K562 IFNg6h","url":"http://egg.wustl.edu/d/hg19/GSM935473_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24003","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNg6h","treatment description":"Interferon gamma treatment - 6 hours (Snyder)","antibody":"Pol2","antibody antibodydescription":"mouse monoclonal, clone 8WG16. Antibody Target: POL2","antibody targetdescription":"RNA Polymerase II","antibody vendorname":"Covance","antibody vendorid":"MMS-126R","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000658","replicate":"1","original_filename":"GSM935473_hg19_wgEncodeSydhTfbsK562Pol2Ifng6hStdSig.bigWig"},"geolst":["GSM935473"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 STAT5A","url":"http://egg.wustl.edu/d/hg19/GSM1010877_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24690","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Mouse monoclonal IgG, recommended for the detection of Stat5a and Stat5b of human origin by WB, IP, IF and ELISA. Antibody Target: STAT5A","antibody targetdescription":"The protein encoded by this gene is a member of the STAT family of transcription factors. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein is activated by, and mediates the responses of many cell ligands, such as IL2, IL3, IL7 GM-CSF, erythropoietin, thrombopoietin, and different growth hormones. Activation of this protein in myeloma and lymphoma associated with a TEL/JAK2 gene fusion is independent of cell stimulus and has been shown to be essential for the tumorigenesis. The mouse counterpart of this gene is found to induce the expression of BCL2L1/BCL-X(L), which suggests the antiapoptotic function of this gene in cells. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-74442","controlid":"SL6023,SL9103","labexpid":"SL9116,SL8673","softwareversion":"MACS","cell sex":"F","antibody":"STAT5A_(SC-74442)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010877_hg19_wgEncodeHaibTfbsK562Stat5asc74442V0422111RawRep1.bigWig"},"geolst":["GSM1010877"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 STAT5A","url":"http://egg.wustl.edu/d/hg19/GSM1010877_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24690","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Mouse monoclonal IgG, recommended for the detection of Stat5a and Stat5b of human origin by WB, IP, IF and ELISA. Antibody Target: STAT5A","antibody targetdescription":"The protein encoded by this gene is a member of the STAT family of transcription factors. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein is activated by, and mediates the responses of many cell ligands, such as IL2, IL3, IL7 GM-CSF, erythropoietin, thrombopoietin, and different growth hormones. Activation of this protein in myeloma and lymphoma associated with a TEL/JAK2 gene fusion is independent of cell stimulus and has been shown to be essential for the tumorigenesis. The mouse counterpart of this gene is found to induce the expression of BCL2L1/BCL-X(L), which suggests the antiapoptotic function of this gene in cells. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-74442","controlid":"SL6023,SL9103","labexpid":"SL9116,SL8673","softwareversion":"MACS","cell sex":"F","antibody":"STAT5A_(SC-74442)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010877_hg19_wgEncodeHaibTfbsK562Stat5asc74442V0422111RawRep2.bigWig"},"geolst":["GSM1010877"]},{"type":"bigWig","name":"Yale ChipSeq K562 IFNa6h","url":"http://egg.wustl.edu/d/hg19/GSM935471_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24620","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNa6h","treatment description":"Interferon alpha treatment - 6 hours (Snyder)","antibody":"STAT1","antibody antibodydescription":"rabbit polyclonal to STAT1 (alpha) p-91 (C-24). Antibody Target: STAT1","antibody targetdescription":"transcription factor, activated by interferon signalling","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-345","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000656","replicate":"1","original_filename":"GSM935471_hg19_wgEncodeSydhTfbsK562Stat1Ifna6hStdSig.bigWig"},"geolst":["GSM935471"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 RevXlinkChromatin","url":"http://egg.wustl.edu/d/hg19/GSM803468_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24017","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"RevXlinkChromatin","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2455","replicate":"1","replicate description":"tier 1","original_filename":"GSM803468_hg19_wgEncodeHaibTfbsK562RxlchV0416101RawRep1.bigWig"},"geolst":["GSM803468"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 RevXlinkChromatin","url":"http://egg.wustl.edu/d/hg19/GSM803468_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24017","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"RevXlinkChromatin","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2455","replicate":"1","replicate description":"tier 1","original_filename":"GSM803468_hg19_wgEncodeHaibTfbsK562RxlchV0416101RawRep2.bigWig"},"geolst":["GSM803468"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 RevXlinkChromatin","url":"http://egg.wustl.edu/d/hg19/GSM1010894_4.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24017","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","controlid":"SL12793,SL6023,SL11659,SL9103","labexpid":"SL12793,SL6023,SL11659,SL9103","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"RevXlinkChromatin","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,3,2,4","original_filename":"GSM1010894_hg19_wgEncodeHaibTfbsK562RxlchV0422111RawRep4.bigWig"},"geolst":["GSM1010894"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 RevXlinkChromatin","url":"http://egg.wustl.edu/d/hg19/GSM1010894_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24017","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","controlid":"SL12793,SL6023,SL11659,SL9103","labexpid":"SL12793,SL6023,SL11659,SL9103","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"RevXlinkChromatin","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,3,2,4","original_filename":"GSM1010894_hg19_wgEncodeHaibTfbsK562RxlchV0422111RawRep1.bigWig"},"geolst":["GSM1010894"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 RevXlinkChromatin","url":"http://egg.wustl.edu/d/hg19/GSM1010894_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24017","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","controlid":"SL12793,SL6023,SL11659,SL9103","labexpid":"SL12793,SL6023,SL11659,SL9103","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"RevXlinkChromatin","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,3,2,4","original_filename":"GSM1010894_hg19_wgEncodeHaibTfbsK562RxlchV0422111RawRep2.bigWig"},"geolst":["GSM1010894"]},{"type":"bigWig","name":"USC ChipSeq K562 E2F6","url":"http://egg.wustl.edu/d/hg19/GSM935597_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24060","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"E2F6","antibody antibodydescription":"Rabbit polyclonal IgG, epitope corresponding to a.a. 232-281 mapping at the C-terminus of E2F-6 of human origin. Antibody Target: E2F6","antibody targetdescription":"This gene encodes a member of the E2F transcription factor protein family. E2F family members play a crucial role in control of the cell cycle and of the action of tumor suppressor proteins. They are also a target of the transforming proteins of small DNA tumor viruses. Many E2F proteins contain several evolutionarily conserved domains: a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. The encoded protein of this gene is atypical because it lacks the transactivation and tumor suppressor protein association domains. It contains a modular suppression domain and is an inhibitor of E2F-dependent transcription. The protein is part of a multimeric protein complex that contains a histone methyltransferase and the transcription factors Mga and Max. Multiple transcript variants have been reported for this gene, but it has not been clearly demonstrated that they encode valid isoforms (RefSeq).","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-22823","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","labversion":"Fragmented using Bioruptor, precipitated with StaphA PeakSeq 1.0 (fdr 0.001) Lane A is Illumina 2.0, low confidence sequences excluded","replicate":"1","original_filename":"GSM935597_hg19_wgEncodeSydhTfbsK562E2f6UcdSig.bigWig"},"geolst":["GSM935597"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 CEBPD","url":"http://egg.wustl.edu/d/hg19/GSM1010906_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24689","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping at the C-terminus of CEBPD of human origin. Antibody Target: CEBPD","antibody targetdescription":"The protein encoded by this intronless gene is a bZIP transcription factor which can bind as a homodimer to certain DNA regulatory regions. It can also form heterodimers with the related protein CEBP-alpha. The encoded protein is important in the regulation of genes involved in immune and inflammatory responses, and may be involved in the regulation of genes associated with activation and/or differentiation of macrophages. The cytogenetic location of this locus has been reported as both 8p11 and 8q11 (provided by RefSeq).","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-636","controlid":"SL12793,SL11659","labexpid":"SL13317,SL11280","softwareversion":"MACS","cell sex":"F","antibody":"CEBPD_(SC-636)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010906_hg19_wgEncodeHaibTfbsK562Cebpdsc636V0422111RawRep1.bigWig"},"geolst":["GSM1010906"]},{"type":"bigWig","name":"SunyAlbany RipSeq K562 ELAVL1","url":"http://egg.wustl.edu/d/hg19/GSM944523_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24076","30021"],"details":{"lab":"SunyAlbany","lab description":"Tenenbaum - SUNY at Albany","datatype":"RipSeq","datatype description":"RNA IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"ELAVL1","antibody antibodydescription":"1) Mouse monocloanal vs HuR, Hel-N1, HuC and HuD of mus, rat, hum and Xenopus origin","antibody targetdescription":"(Embryonic lethal, abnormal vision, Drosophila)-like 1 (Huantigen R) (Homo sapiens)","antibody vendorname":"1) Santa Cruz Biotech","antibody vendorid":"SC-5261","labversion":"SC_5261 antibody","replicate":"1","original_filename":"GSM944523_hg19_wgEncodeSunyRipSeqK562Elavl1SigRep1.bigWig"},"geolst":["GSM944523"]},{"type":"bigWig","name":"Stanford ChipSeq K562 ARID3A","url":"http://egg.wustl.edu/d/hg19/GSM935336_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24602","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"ARID3A_(sc-8821)","antibody antibodydescription":"affinity purified goat polyclonal antibody raised against a peptide mapping at the N-terminus of ARID3A of human origin. Antibody Target: ARID3A","antibody targetdescription":"This gene encodes a member of the ARID (AT-rich interaction domain) family of DNA binding proteins. It was found by homology to the Drosophila dead ringer gene, which is important for normal embryogenesis. Other ARID family members have roles in embryonic patterning, cell lineage gene regulation, cell cycle control, transcriptional regulation, and possibly in chromatin structure modification. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-8821","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935336_hg19_wgEncodeSydhTfbsK562Arid3asc8821IggrabSig.bigWig"},"geolst":["GSM935336"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 CTCF","url":"http://egg.wustl.edu/d/hg19/GSM1010820_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24001","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Goat polyclonal IgG, epitope mapping at the N-terminus of CTCF of human origin. Antibody Target: CTCF","antibody targetdescription":"This gene is a member of the BORIS + CTCF gene family and encodes a transcriptional regulator protein with 11 highly conserved zinc finger (ZF) domains. This nuclear protein is able to use different combinations of the ZF domains to bind different DNA target sequences and proteins. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-5916","controlid":"SL1396,SL1397","labexpid":"SL3075,SL5605","softwareversion":"MACS","cell sex":"F","antibody":"CTCF_(SC-5916)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"one 15-cycle round of PCR (Myers)","replicate":"1,2","original_filename":"GSM1010820_hg19_wgEncodeHaibTfbsK562CtcfcPcr1xRawRep2.bigWig"},"geolst":["GSM1010820"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 RevXlinkChromatin","url":"http://egg.wustl.edu/d/hg19/GSM803352_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24017","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"RevXlinkChromatin","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL518","labexpid":"SL518","replicate":"1","replicate description":"tier 1","original_filename":"GSM803352_hg19_wgEncodeHaibTfbsK562RxlchPcr1xRawRep1.bigWig"},"geolst":["GSM803352"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 RevXlinkChromatin","url":"http://egg.wustl.edu/d/hg19/GSM803352_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24017","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"RevXlinkChromatin","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL518","labexpid":"SL518","replicate":"1","replicate description":"tier 1","original_filename":"GSM803352_hg19_wgEncodeHaibTfbsK562RxlchPcr1xRawRep2.bigWig"},"geolst":["GSM803352"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 RevXlinkChromatin","url":"http://egg.wustl.edu/d/hg19/GSM803352_4.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24017","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"RevXlinkChromatin","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL518","labexpid":"SL518","replicate":"1","replicate description":"tier 1","original_filename":"GSM803352_hg19_wgEncodeHaibTfbsK562RxlchPcr1xRawRep4.bigWig"},"geolst":["GSM803352"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 HEY1","url":"http://egg.wustl.edu/d/hg19/GSM803385_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24034","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"HEY1","antibody antibodydescription":"HRT1 (C-20) Goat polyclonal IgG, 200 ?g/ml. Epitope mapping near the C-terminus of HRT1 of human origin","antibody targetdescription":"This gene encodes a nuclear protein belonging to the hairy and enhancer of split-related (HESR) family of basic helix-loop-helix (bHLH)-type transcriptional repressors. Expression of this gene is induced by the Notch and c-Jun signal transduction pathways. Two similar and redundant genes in mouse are required for embryonic cardiovascular development, and are also implicated in neurogenesis and somitogenesis. Alternative splicing results in multiple transcript variants.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-16424","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL518","labexpid":"SL845","replicate":"1","replicate description":"tier 1","original_filename":"GSM803385_hg19_wgEncodeHaibTfbsK562Hey1Pcr1xRawRep2.bigWig"},"geolst":["GSM803385"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 TAF7","url":"http://egg.wustl.edu/d/hg19/GSM803407_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24046","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"TAF7_(SC-101167)","antibody antibodydescription":"Mouse monoclonal IgG, raised against recombinant TAF II p55 (TAF7) of human origin.","antibody targetdescription":"The intronless gene for this transcription coactivator is located between the protocadherin beta and gamma gene clusters on chromosome 5. The protein encoded by this gene is a component of the TFIID protein complex, a complex which binds to the TATA box in class II promoters and recruits RNA polymerase II and other factors. This particular subunit interacts with the largest TFIID subunit, as well as multiple transcription activators. The protein is required for transcription by promoters targeted by RNA polymerase II (RefSeq).","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-101167","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3274","replicate":"1","replicate description":"tier 1","original_filename":"GSM803407_hg19_wgEncodeHaibTfbsK562Taf7sc101167V0416101RawRep2.bigWig"},"geolst":["GSM803407"]},{"type":"bigWig","name":"Stanford ChipSeq K562 IFNg6h","url":"http://egg.wustl.edu/d/hg19/GSM935549_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24652","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNg6h","treatment description":"Interferon gamma treatment - 6 hours (Snyder)","antibody":"IRF1","antibody antibodydescription":"IRF-1 (C-20) is an affinity purified rabbit polyclonal antibody raised against a peptide mapping at the C-terminus of IRF-1 of human origin. Antibody Target: IRF1","antibody targetdescription":"Interferon regulatory factor 1 is a member of the interferon regulatory transcription factor (IRF) family. IRF1 serves as an activator of interferons alpha and beta transcription and also functions as a transcription activator of genes induced by interferons alpha, beta, and gamma. IRF1 has been shown to play roles in regulating apoptosis and tumor suppression.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-497","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000658","replicate":"1","original_filename":"GSM935549_hg19_wgEncodeSydhTfbsK562Irf1Ifng6hStdSig.bigWig"},"geolst":["GSM935549"]},{"type":"bigWig","name":"USC ChipSeq K562 SETDB1","url":"http://egg.wustl.edu/d/hg19/GSM935598_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24619","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"SETDB1","antibody antibodydescription":"Rabbit polyclonal. Antibody Target: SETDB1","antibody targetdescription":"SET domain, bifurcated 1, the SET domain is a highly conserved, approximately 150-amino acid motif implicated in the modulation of chromatin structure","antibody vendorname":"Proteintech Group","antibody vendorid":"11231-1-AP","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","labversion":"Fragmented using Bioruptor, precipitated with StaphA","replicate":"1","softwareversion":"PeakSeq1.0 (fdr 0.001)","original_filename":"GSM935598_hg19_wgEncodeSydhTfbsK562Setdb1UcdSig.bigWig"},"geolst":["GSM935598"]},{"type":"bigWig","name":"Harvard ChipSeq K562 CCNT2","url":"http://egg.wustl.edu/d/hg19/GSM935547_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24666","30020"],"details":{"lab":"Harvard","lab description":"Struhl - Harvard University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"CCNT2","antibody antibodydescription":"Goal polyclonal. Raised against an internal region of human CycT2a/b. Recommeded for detection of CycT2a/b of rat, mouse or human origin. Vendor recommeds it use for the folloiwng applications: WB, IF and ELISA. Antibody Target: CCNT2","antibody targetdescription":"CycT2 is one of three cyclins that can form a heterodimer with cyclin-dependent kinase 9 (CDK9). The heterodimer is known as positive elongation factor b (P-TEFb) and is responsible for the phosphophorylation of Ser2 of the heptad repeat in the C-terminal domain of RNA polymerase II as well as the negative elongation factors DSIF (hSpt4/hSpt5) and NELF. Phosphorylation of RNA polymerase II and the negative elongation factors by P-TEFb promotes elongation. CycT2 contains a leucine rich domain capable of binding to the C-terminal domain of RNA polymerase II.","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-12419","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","replicate":"1","original_filename":"GSM935547_hg19_wgEncodeSydhTfbsK562Ccnt2StdSig.bigWig"},"geolst":["GSM935547"]},{"type":"bigWig","name":"Bernstein K562 Pol2(b)","url":"http://egg.wustl.edu/d/hg19/GSM733643_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24002","30003"],"details":{"cell":"K562","cell organism":"Human","cell description":"leukemia","cell karyotype":"cancer","cell lineage":"The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell sex":"F","antibody":"Pol2(b)","antibody description":"mouse monoclonal, clone CTD4H8","antibody target description":"RNA polymerase II. Is responsible for RNA transcription. It is generally enriched at 5' gene ends, probably due to higher rate of occupancy associated with transition from initiation to elongation.","antibody vendor name":"Covance","original_filename":"GSM733643_hg19_wgEncodeBroadHistoneK562Pol2bStdSig.bigWig"},"geolst":["GSM733643"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 NR2F2","url":"http://egg.wustl.edu/d/hg19/GSM1010782_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24681","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Mouse monoclonal IgG, specific for an epitope mapping between amino acids 13-44 at the N-terminus of NR2F2 of human origin. Antibody Target: NR2F2","antibody targetdescription":"This gene encodes a member of the steroid thyroid hormone superfamily of nuclear receptors. The encoded protein is a ligand inducible transcription factor that is involved in the regulation of many different genes. Alternate splicing results in multiple transcript variants. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-271940","controlid":"SL6023","labexpid":"SL8577,SL8143","softwareversion":"MACS","cell sex":"F","antibody":"NR2F2_(SC-271940)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010782_hg19_wgEncodeHaibTfbsK562Nr2f2sc271940V0422111RawRep2.bigWig"},"geolst":["GSM1010782"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 NR2F2","url":"http://egg.wustl.edu/d/hg19/GSM1010782_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24681","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Mouse monoclonal IgG, specific for an epitope mapping between amino acids 13-44 at the N-terminus of NR2F2 of human origin. Antibody Target: NR2F2","antibody targetdescription":"This gene encodes a member of the steroid thyroid hormone superfamily of nuclear receptors. The encoded protein is a ligand inducible transcription factor that is involved in the regulation of many different genes. Alternate splicing results in multiple transcript variants. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-271940","controlid":"SL6023","labexpid":"SL8577,SL8143","softwareversion":"MACS","cell sex":"F","antibody":"NR2F2_(SC-271940)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010782_hg19_wgEncodeHaibTfbsK562Nr2f2sc271940V0422111RawRep1.bigWig"},"geolst":["GSM1010782"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 SIX5","url":"http://egg.wustl.edu/d/hg19/GSM803378_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24016","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"SIX5","antibody antibodydescription":"Six5 (K-20) Goat polyclonal IgG, 200?g/ml. Epitope mapping near the C-terminus of Six5 of human origin. Recommended for detection of Six5 of human origin by WB, IF and ELISA","antibody targetdescription":"The protein encoded by this gene is a homeodomain-containing transcription factor that appears to function in the regulation of organogenesis. This gene is located downstream of the dystrophia myotonica-protein kinase gene. Mutations in this geneare a cause of branchiootorenal syndrome type 2.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-55706","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3924","replicate":"1","replicate description":"tier 1","original_filename":"GSM803378_hg19_wgEncodeHaibTfbsK562Six5V0416101RawRep1.bigWig"},"geolst":["GSM803378"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 SIX5","url":"http://egg.wustl.edu/d/hg19/GSM803378_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24016","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"SIX5","antibody antibodydescription":"Six5 (K-20) Goat polyclonal IgG, 200?g/ml. Epitope mapping near the C-terminus of Six5 of human origin. Recommended for detection of Six5 of human origin by WB, IF and ELISA","antibody targetdescription":"The protein encoded by this gene is a homeodomain-containing transcription factor that appears to function in the regulation of organogenesis. This gene is located downstream of the dystrophia myotonica-protein kinase gene. Mutations in this geneare a cause of branchiootorenal syndrome type 2.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-55706","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3924","replicate":"1","replicate description":"tier 1","original_filename":"GSM803378_hg19_wgEncodeHaibTfbsK562Six5V0416101RawRep2.bigWig"},"geolst":["GSM803378"]},{"type":"bigWig","name":"Stanford ChipSeq K562 TBP","url":"http://egg.wustl.edu/d/hg19/GSM935495_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24630","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"TBP","antibody antibodydescription":"Mouse monoclonal. Immunogen is synthetic peptide conjugated to KLH derived from within residues 1 - 100 of HumanTATA binding protein TBP. Antibody Target: TBP","antibody targetdescription":"General transcription factor that functions at the core of the DNA-binding multiprotein factor TFIID. Binding of TFIID to the TATA box is the initial transcriptional step of the pre-initiation complex (PIC), playing a role in the activation of eukaryotic genes transcribed by RNA polymerase II. Component of the transcription factor SL1/TIF-IB complex, which is involved in the assembly of the PIC (preinitiation complex) during RNA polymerase I-dependent transcription.","antibody vendorname":"abcam","antibody vendorid":"ab62126","control":"IgG-mus","control description":"Input signal from Normal Mouse IgG ChIP-seq.","controlid":"wgEncodeEH000726","replicate":"1","original_filename":"GSM935495_hg19_wgEncodeSydhTfbsK562TbpIggmusSig.bigWig"},"geolst":["GSM935495"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 TRIM28","url":"http://egg.wustl.edu/d/hg19/GSM1010849_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24682","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Mouse monoclonal IgG, raised against a recombinant protein corresponding to an internal region of TRIM28 of human origin. Antibody Target: TRIM28","antibody targetdescription":"The protein encoded by this gene mediates transcriptional control by interaction with the Kruppel-associated box repression domain found in many transcription factors.  The protein localizes to the nucleus and is thought to associate with specific chromatin regions.  The protein is a member of the tripartite motif family.  This tripartite motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-81411","controlid":"SL6023","labexpid":"SL9830,SL8672","softwareversion":"MACS","cell sex":"F","antibody":"TRIM28_(SC-81411)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010849_hg19_wgEncodeHaibTfbsK562Trim28sc81411V0422111RawRep2.bigWig"},"geolst":["GSM1010849"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 TRIM28","url":"http://egg.wustl.edu/d/hg19/GSM1010849_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24682","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Mouse monoclonal IgG, raised against a recombinant protein corresponding to an internal region of TRIM28 of human origin. Antibody Target: TRIM28","antibody targetdescription":"The protein encoded by this gene mediates transcriptional control by interaction with the Kruppel-associated box repression domain found in many transcription factors.  The protein localizes to the nucleus and is thought to associate with specific chromatin regions.  The protein is a member of the tripartite motif family.  This tripartite motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-81411","controlid":"SL6023","labexpid":"SL9830,SL8672","softwareversion":"MACS","cell sex":"F","antibody":"TRIM28_(SC-81411)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010849_hg19_wgEncodeHaibTfbsK562Trim28sc81411V0422111RawRep1.bigWig"},"geolst":["GSM1010849"]},{"type":"bigWig","name":"Yale ChipSeq K562 IFNa6h","url":"http://egg.wustl.edu/d/hg19/GSM935468_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24603","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNa6h","treatment description":"Interferon alpha treatment - 6 hours (Snyder)","antibody":"c-Jun","antibody antibodydescription":"Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun","antibody targetdescription":"Heterodimer of Fos and Jun constitute transcription factor AP1.  Proto-oncogene c-Jun is a leucine-zipper.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-1694","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000656","labversion":"remapped from hg18","replicate":"1","original_filename":"GSM935468_hg19_wgEncodeSydhTfbsK562CjunIfna6hStdSig.bigWig"},"geolst":["GSM935468"]},{"type":"bigWig","name":"Stam K562 CTCF 2","url":"http://egg.wustl.edu/d/hg19/GSM749733_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24001","30004"],"details":{"cell":"K562","cell organism":"Human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"CTCF","antibody description":"rabbit polyclonal","antibody target description":"CTCF zinc finger transcription factor. A sequence specific DNA binding protein that functions as an insulator, blocking enhancer activity. It has also been suggested to block the spreading of chromatin structure in certain instances.","antibody vendor name":"Millipore","replicate":"2","original_filename":"GSM749733_hg19_wgEncodeUwTfbsK562CtcfStdRawRep2.bigWig"},"geolst":["GSM749733"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 ATF3","url":"http://egg.wustl.edu/d/hg19/GSM803380_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24031","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"ATF3","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping at the C-terminus of ATF3 of human origin.","antibody targetdescription":"Activating transcription factor 3. A bZIP transcription factor and member of the Ca2+/cAMP response element-binding (CREB) protein family. ATF3 is found to act both as an activator and repressor of transcription.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-188","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3184","replicate":"1","replicate description":"tier 1","original_filename":"GSM803380_hg19_wgEncodeHaibTfbsK562Atf3V0416101RawRep1.bigWig"},"geolst":["GSM803380"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 ATF3","url":"http://egg.wustl.edu/d/hg19/GSM803380_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24031","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"ATF3","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping at the C-terminus of ATF3 of human origin.","antibody targetdescription":"Activating transcription factor 3. A bZIP transcription factor and member of the Ca2+/cAMP response element-binding (CREB) protein family. ATF3 is found to act both as an activator and repressor of transcription.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-188","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3184","replicate":"1","replicate description":"tier 1","original_filename":"GSM803380_hg19_wgEncodeHaibTfbsK562Atf3V0416101RawRep2.bigWig"},"geolst":["GSM803380"]},{"type":"bigWig","name":"Stanford ChipSeq K562 IFNg30","url":"http://egg.wustl.edu/d/hg19/GSM935548_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24004","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNg30","treatment description":"Interferon gamma treatment - 30 minutes (Snyder)","antibody":"c-Myc","antibody antibodydescription":"rabbit polyclonal to amino acids 1-262 of c-Myc human origin. Antibody Target: c-Myc","antibody targetdescription":"transcription factor","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-764","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000657","replicate":"1","original_filename":"GSM935548_hg19_wgEncodeSydhTfbsK562CmycIfng30StdSig.bigWig"},"geolst":["GSM935548"]},{"type":"bigWig","name":"USC ChipSeq K562 GATA-1","url":"http://egg.wustl.edu/d/hg19/GSM935540_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24610","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"GATA-1","antibody antibodydescription":"Anti-GATA-1 rabbit polyclonal antibody was generated by using a purified GST fusion to amino acids 1-89 of mouse GATA-1. Antibody Target: GATA1","antibody targetdescription":"GATA-1 is a transcriptional activator which probably serves as a general switch factor for erythroid development. It binds to DNA sites with the consensus sequence [AT]GATA[AG} within regulatory regions of globin genes and of other genes expressed in erythroid cells.","antibody vendorname":"Donated by Dr. E.H. Bresnick, UW Madison","antibody vendorid":"GATA-1","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","labversion":"Fragmented using Bioruptor, precipitated with protein A agarose beads,","replicate":"1","softwareversion":"PeakSeq1.0 (fdr 0.001)","original_filename":"GSM935540_hg19_wgEncodeSydhTfbsK562Gata1UcdSig.bigWig"},"geolst":["GSM935540"]},{"type":"bigWig","name":"Harvard ChipSeq K562 ATF3","url":"http://egg.wustl.edu/d/hg19/GSM935391_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24031","30020"],"details":{"lab":"Harvard","lab description":"Struhl - Harvard University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"ATF3","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping at the C-terminus of ATF3 of human origin. Antibody Target: ATF3","antibody targetdescription":"Activating transcription factor 3. A bZIP transcription factor and member of the Ca2+/cAMP response element-binding (CREB) protein family. ATF3 is found to act both as an activator and repressor of transcription.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-188","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","replicate":"1","original_filename":"GSM935391_hg19_wgEncodeSydhTfbsK562Atf3StdSig.bigWig"},"geolst":["GSM935391"]},{"type":"bigWig","name":"Stanford ChipSeq K562 Brg1","url":"http://egg.wustl.edu/d/hg19/GSM935633_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24658","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Brg1","antibody antibodydescription":"Brg-1 (G-7) is a mouse monoclonal antibody raised against amino acids 209-296 mapping near the N-terminus of Brg-1 of human origin. Antibody Target: BRG1","antibody targetdescription":"Brg1 (SMARCA4) is an ATPase subunit of the SWI/SNF chromatin-remodeling complex.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-17796","control":"IgG-mus","control description":"Input signal from Normal Mouse IgG ChIP-seq.","controlid":"wgEncodeEH000726","labversion":"remapped from hg18, Illumina 2.0, low confidence sequences excluded. Data paired with IgG_Control.","replicate":"1","original_filename":"GSM935633_hg19_wgEncodeSydhTfbsK562Brg1IggmusSig.bigWig"},"geolst":["GSM935633"]},{"type":"bigWig","name":"Harvard ChipSeq K562 ATF1","url":"http://egg.wustl.edu/d/hg19/GSM935340_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24641","30020"],"details":{"lab":"Harvard","lab description":"Struhl - Harvard University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"ATF1_(06-325)","antibody antibodydescription":"Sheep polyclonal, immunogen: CPVTLTSQTTKTDDPQL. Antibody Target: ATF1","antibody targetdescription":"ATF1 is a bZip transcription factor from the CREB family.  ATF1 binds to both cAMP response elements (TGACGTCA).","antibody vendorname":"Millipore","antibody vendorid":"06-325","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","replicate":"1","original_filename":"GSM935340_hg19_wgEncodeSydhTfbsK562Atf106325StdSig.bigWig"},"geolst":["GSM935340"]},{"type":"bigWig","name":"Stanford ChipSeq K562 Max","url":"http://egg.wustl.edu/d/hg19/GSM935344_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24066","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Max","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping at the C-terminus of Max of human origin. Antibody Target: Max","antibody targetdescription":"The protein encoded by this gene is a member of the basic helix-loop-helix leucine zipper (bHLHZ) family of transcription factors. It is able to form homodimers and heterodimers with other family members, which include Mad, Mxi1 and Myc. Myc is an oncoprotein implicated in cell proliferation, differentiation and apoptosis. The homodimers and heterodimers compete for a common DNA target site (the E box) and rearrangement among these dimer forms provides a complex system of transcriptional regulation. Multiple alternatively spliced transcript variants have been described for this gene but the full-length nature for some of them is unknown (RefSeq).","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-197","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935344_hg19_wgEncodeSydhTfbsK562MaxIggrabSig.bigWig"},"geolst":["GSM935344"]},{"type":"bigWig","name":"Yale ChipSeq K562 IFNg6h","url":"http://egg.wustl.edu/d/hg19/GSM935467_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24603","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNg6h","treatment description":"Interferon gamma treatment - 6 hours (Snyder)","antibody":"c-Jun","antibody antibodydescription":"Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun","antibody targetdescription":"Heterodimer of Fos and Jun constitute transcription factor AP1.  Proto-oncogene c-Jun is a leucine-zipper.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-1694","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000658","labversion":"remapped from hg18","replicate":"1","original_filename":"GSM935467_hg19_wgEncodeSydhTfbsK562CjunIfng6hStdSig.bigWig"},"geolst":["GSM935467"]},{"type":"bigWig","name":"UChicago ChipSeq K562 eGFP-HDAC8","url":"http://egg.wustl.edu/d/hg19/GSM777640_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24007","30013"],"details":{"lab":"UChicago","lab description":"White - University of Chicago","data type":"ChipSeq","data type description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"eGFP-HDAC8","antibody antibody description":"Goat polyclonal","antibody target description":"HDAC8","antibody vendor name":"Kevin White","antibody vendor id":"(None)","control":"Control_eGFP-HDAC8","control description":"This data represents a control being compared to experiments using antibody eGFP-HDAC8","control id":"K562/Input/Control_eGFP-HDAC8","replicate":"1","replicate description":"tier 1","original_filename":"GSM777640_wgEncodeUchicagoTfbsK562Ehdac8ControlSig.bigWig"},"geolst":["GSM777640"]},{"type":"bigWig","name":"Yale ChipSeq K562 IFNg30","url":"http://egg.wustl.edu/d/hg19/GSM935602_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24603","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNg30","treatment description":"Interferon gamma treatment - 30 minutes (Snyder)","antibody":"c-Jun","antibody antibodydescription":"Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun","antibody targetdescription":"Heterodimer of Fos and Jun constitute transcription factor AP1.  Proto-oncogene c-Jun is a leucine-zipper.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-1694","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000657","labversion":"remapped from hg18","replicate":"1","original_filename":"GSM935602_hg19_wgEncodeSydhTfbsK562CjunIfng30StdSig.bigWig"},"geolst":["GSM935602"]},{"type":"bigWig","name":"Stanford ChipSeq K562 GATA1","url":"http://egg.wustl.edu/d/hg19/GSM1003608_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24700","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"GATA1_(SC-266)","antibody antibodydescription":"Rat monoclonal raised against bacterially expressed murine GATA-1. Antibody Target:  GATA1","antibody targetdescription":"GATA1 is erythroid-specific and is responsible for the regulated transcription of erythroid genes.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-266","control":"IgG-mus","control description":"Input signal from Normal Mouse IgG ChIP-seq.","controlid":"wgEncodeEH000726","original_filename":"GSM1003608_hg19_wgEncodeSydhTfbsK562Gata1bIggmusSig.bigWig"},"geolst":["GSM1003608"]},{"type":"bigWig","name":"Broad ChipSeq K562 CHD4","url":"http://egg.wustl.edu/d/hg19/GSM1003510_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24702","30003"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Rabbit Polyclonal Antigen Affinity Purified, Unconjugated, Liquid","antibody targetdescription":"CHD4/Mi2beta is a helicase component of the nucleosome remodeling and deacetylase (NuRD) complex that functions to remodel chromatin and repress transcription. Outside of the NuRD complex, CHD4/Mi2beta can function as an activator of transcription in association with p300 histone acetyltransferase.","antibody vendorname":"Bethyl","antibody vendorid":"A301-081A","controlid":"K562/None/Input/std","replicate":"1","softwareversion":"ScriptureVPaperR3","cell sex":"F","antibody":"CHD4_Mi2","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","labversion":"Illumina_HiSeq_2000","labversion description":"Illumina HiSeq 2000","original_filename":"GSM1003510_hg19_wgEncodeBroadHistoneK562Chd4mi2Sig.bigWig"},"geolst":["GSM1003510"]},{"type":"bigWig","name":"Stanford ChipSeq K562 Mxi1","url":"http://egg.wustl.edu/d/hg19/GSM935497_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24623","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Mxi1_(AF4185)","antibody antibodydescription":"Goat IgG. Raised against E. coli-derived rhMxi1. Antibody Target: Mxi1","antibody targetdescription":"Transcriptional repressor. Binds with MAX to form recognize the core sequence 5'-CAC[GA]TG-3', antagonizes MYC transcriptional activity by competing for MAX","antibody vendorname":"R&D Systems","antibody vendorid":"AF4185","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935497_hg19_wgEncodeSydhTfbsK562Mxi1af4185IggrabSig.bigWig"},"geolst":["GSM935497"]},{"type":"bigWig","name":"USC ChipSeq K562 E2F4","url":"http://egg.wustl.edu/d/hg19/GSM935600_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24609","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"E2F4","antibody antibodydescription":"rabbit polyclonal. Antibody Target: E2F4","antibody targetdescription":"mapping at the C-terminus of E2F4 of human origin","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-866","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","labversion":"Fragmented using Bioruptor, precipitated with StaphA (replicate 1) or protein A agarose beads (replicate 2), PeakSeq 1.0 (fdr 0.001) Illumina 2.0, low confidence sequences excluded","replicate":"1","original_filename":"GSM935600_hg19_wgEncodeSydhTfbsK562E2f4UcdSig.bigWig"},"geolst":["GSM935600"]},{"type":"bigWig","name":"Yale ChipSeq K562 c-Myc","url":"http://egg.wustl.edu/d/hg19/GSM935410_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24004","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"c-Myc","antibody antibodydescription":"rabbit polyclonal to amino acids 1-262 of c-Myc human origin. Antibody Target: c-Myc","antibody targetdescription":"transcription factor","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-764","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","replicate":"1","original_filename":"GSM935410_hg19_wgEncodeSydhTfbsK562CmycStdSig.bigWig"},"geolst":["GSM935410"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 SRF","url":"http://egg.wustl.edu/d/hg19/GSM803520_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24023","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"SRF","antibody antibodydescription":"Rabbit polyclonal","antibody targetdescription":"Serum response transcription factor","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-335","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3162","replicate":"1","replicate description":"tier 1","original_filename":"GSM803520_hg19_wgEncodeHaibTfbsK562SrfV0416101RawRep1.bigWig"},"geolst":["GSM803520"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 SRF","url":"http://egg.wustl.edu/d/hg19/GSM803520_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24023","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"SRF","antibody antibodydescription":"Rabbit polyclonal","antibody targetdescription":"Serum response transcription factor","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-335","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3162","replicate":"1","replicate description":"tier 1","original_filename":"GSM803520_hg19_wgEncodeHaibTfbsK562SrfV0416101RawRep2.bigWig"},"geolst":["GSM803520"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 GABP","url":"http://egg.wustl.edu/d/hg19/GSM803524_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24021","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"GABP","antibody antibodydescription":"Mouse monoclonal, GABPa(G-1), IgG1","antibody targetdescription":"The transcription factor GA-binding protein (GABP) is composed of two subunits, alpha and beta. Alpha binds to a specific DNA sequence.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-28312","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2943","replicate":"1","replicate description":"tier 1","original_filename":"GSM803524_hg19_wgEncodeHaibTfbsK562GabpV0416101RawRep1.bigWig"},"geolst":["GSM803524"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 GABP","url":"http://egg.wustl.edu/d/hg19/GSM803524_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24021","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"GABP","antibody antibodydescription":"Mouse monoclonal, GABPa(G-1), IgG1","antibody targetdescription":"The transcription factor GA-binding protein (GABP) is composed of two subunits, alpha and beta. Alpha binds to a specific DNA sequence.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-28312","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2943","replicate":"1","replicate description":"tier 1","original_filename":"GSM803524_hg19_wgEncodeHaibTfbsK562GabpV0416101RawRep2.bigWig"},"geolst":["GSM803524"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 YY1","url":"http://egg.wustl.edu/d/hg19/GSM803446_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24025","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"YY1","antibody antibodydescription":"Rabbit polyclonal","antibody targetdescription":"YIN YANG 1 transcription factor belongs to the GLI-Kruppel class of zinc finger proteins.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-1703","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2203","replicate":"1","replicate description":"tier 1","original_filename":"GSM803446_hg19_wgEncodeHaibTfbsK562Yy1V0416101RawRep1.bigWig"},"geolst":["GSM803446"]},{"type":"bigWig","name":"K562 P300","url":"http://egg.wustl.edu/d/hg19/GSM831006_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24011","30003"],"details":{"cell type":"K562 erythrocytic leukaemia cells (ATCC CCL-243)","chip antibody":"Bethyl,A300-358A","original_filename":"GSM831006_K562_P300.bw"},"geolst":["GSM831006"]},{"type":"bigWig","name":"UT-A ChipSeq K562 Pol2","url":"http://egg.wustl.edu/d/hg19/GSM822275_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24003","30009"],"details":{"lab":"UT-A","lab description":"Iyer - University of Texas at Austin","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"Pol2","antibody antibodydescription":"mouse monoclonal, clone 8WG16","antibody targetdescription":"RNA Polymerase II","antibody vendorname":"Covance","antibody vendorid":"MMS-126R","controlid":"K562/Input","labversion":"align_on_cluster_bwa.pl v 1","replicate":"1","replicate description":"tier 1","original_filename":"GSM822275_hg19_wgEncodeOpenChromChipK562Pol2BaseOverlapSignal.bigWig"},"geolst":["GSM822275"]},{"type":"bigWig","name":"UT-A ChipSeq K562 Pol2","url":"http://egg.wustl.edu/d/hg19/GSM822275_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24003","30009"],"details":{"lab":"UT-A","lab description":"Iyer - University of Texas at Austin","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"Pol2","antibody antibodydescription":"mouse monoclonal, clone 8WG16","antibody targetdescription":"RNA Polymerase II","antibody vendorname":"Covance","antibody vendorid":"MMS-126R","controlid":"K562/Input","labversion":"align_on_cluster_bwa.pl v 1","replicate":"1","replicate description":"tier 1","original_filename":"GSM822275_hg19_wgEncodeOpenChromChipK562Pol2Sig.bigWig"},"geolst":["GSM822275"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 YY1","url":"http://egg.wustl.edu/d/hg19/GSM803446_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24025","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"YY1","antibody antibodydescription":"Rabbit polyclonal","antibody targetdescription":"YIN YANG 1 transcription factor belongs to the GLI-Kruppel class of zinc finger proteins.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-1703","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2203","replicate":"1","replicate description":"tier 1","original_filename":"GSM803446_hg19_wgEncodeHaibTfbsK562Yy1V0416101RawRep2.bigWig"},"geolst":["GSM803446"]},{"type":"bigWig","name":"SunyAlbany RipSeq K562 PABPC1","url":"http://egg.wustl.edu/d/hg19/GSM944522_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24075","30021"],"details":{"lab":"SunyAlbany","lab description":"Tenenbaum - SUNY at Albany","datatype":"RipSeq","datatype description":"RNA IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"PABPC1","antibody antibodydescription":"Mouse monoclonal vs PABPC1 of human, mouse, bovine, can, hamster, Xenopus origin. Antibody Target: PABPC1","antibody targetdescription":"poly(A) binding protein, cytoplasmic 1 (Homo sapiens).","antibody vendorname":"Sigma Chemical Co.","antibody vendorid":"P6246","labversion":"Sig_P6246 antibody","replicate":"1","original_filename":"GSM944522_hg19_wgEncodeSunyRipSeqK562Pabpc1SigRep1.bigWig"},"geolst":["GSM944522"]},{"type":"bigWig","name":"Stanford ChipSeq K562 IFNg6h","url":"http://egg.wustl.edu/d/hg19/GSM935488_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24620","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNg6h","treatment description":"Interferon gamma treatment - 6 hours (Snyder)","antibody":"STAT1","antibody antibodydescription":"rabbit polyclonal to STAT1 (alpha) p-91 (C-24). Antibody Target: STAT1","antibody targetdescription":"transcription factor, activated by interferon signalling","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-345","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000658","labversion":"low confidence sequences excluded","replicate":"1","original_filename":"GSM935488_hg19_wgEncodeSydhTfbsK562Stat1Ifng6hStdSig.bigWig"},"geolst":["GSM935488"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 SP2","url":"http://egg.wustl.edu/d/hg19/GSM803402_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24043","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"SP2_(SC-643)","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping near the N-terminus of SP2 of human origin.","antibody targetdescription":"This gene encodes a member of the Sp subfamily of Sp/XKLF transcription factors.  Sp family proteins are sequence-specific DNA-binding proteins characterized by an amino-terminal trans-activation domain and three carboxy-terminal zinc finger motifs. This protein contains the least conserved DNA-binding domain within the Sp subfamily of proteins, and its DNA sequence specificity differs from the other Sp proteins.  It localizes primarily within subnuclear foci associated with the nuclear matrix, and can activate or in some cases repress expression from different promoters. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-643","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.2","protocol description":"2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)","controlid":"SL1396","labexpid":"SL2951","replicate":"1","replicate description":"tier 1","original_filename":"GSM803402_hg19_wgEncodeHaibTfbsK562Sp2sc643V0416102RawRep1.bigWig"},"geolst":["GSM803402"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 SP2","url":"http://egg.wustl.edu/d/hg19/GSM803402_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24043","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"SP2_(SC-643)","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping near the N-terminus of SP2 of human origin.","antibody targetdescription":"This gene encodes a member of the Sp subfamily of Sp/XKLF transcription factors.  Sp family proteins are sequence-specific DNA-binding proteins characterized by an amino-terminal trans-activation domain and three carboxy-terminal zinc finger motifs. This protein contains the least conserved DNA-binding domain within the Sp subfamily of proteins, and its DNA sequence specificity differs from the other Sp proteins.  It localizes primarily within subnuclear foci associated with the nuclear matrix, and can activate or in some cases repress expression from different promoters. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-643","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.2","protocol description":"2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)","controlid":"SL1396","labexpid":"SL2951","replicate":"1","replicate description":"tier 1","original_filename":"GSM803402_hg19_wgEncodeHaibTfbsK562Sp2sc643V0416102RawRep2.bigWig"},"geolst":["GSM803402"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 Rad21","url":"http://egg.wustl.edu/d/hg19/GSM803447_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24052","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"Rad21","antibody antibodydescription":"Rabbit polyclonal","antibody targetdescription":"Synthetic peptide (Human) conjugated to KLH - which represents a portion of human Rad21 encoded within exon 14","antibody vendorname":"Abcam","antibody vendorid":"ab992","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.2","protocol description":"2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)","controlid":"SL1396","labexpid":"SL2947","replicate":"1","replicate description":"tier 1","original_filename":"GSM803447_hg19_wgEncodeHaibTfbsK562Rad21V0416102RawRep1.bigWig"},"geolst":["GSM803447"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 Rad21","url":"http://egg.wustl.edu/d/hg19/GSM803447_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24052","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"Rad21","antibody antibodydescription":"Rabbit polyclonal","antibody targetdescription":"Synthetic peptide (Human) conjugated to KLH - which represents a portion of human Rad21 encoded within exon 14","antibody vendorname":"Abcam","antibody vendorid":"ab992","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.2","protocol description":"2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)","controlid":"SL1396","labexpid":"SL2947","replicate":"1","replicate description":"tier 1","original_filename":"GSM803447_hg19_wgEncodeHaibTfbsK562Rad21V0416102RawRep2.bigWig"},"geolst":["GSM803447"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 USF-1","url":"http://egg.wustl.edu/d/hg19/GSM803441_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24022","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"USF-1","antibody antibodydescription":"Rabbit polyclonal, USF-1 (C-20).","antibody targetdescription":"The ubiquitously expressed cellular upstream stimulatory factor (USF) consists of USF-1 and USF-2 polypeptides which independently exhibit site-specific DNA binding and are members of the c-Myc-related family of regulatory factors containing helix-loop-helix domains. USF also contains a leucine repeat that is required for efficient DNA binding. USF was originally identified as an up- stream stimulatory factor that binds the core sequence CACGTG in the adeno- virus late promoter. These findings, together with the demonstration of coop- erative interaction between USF and the initiator-binding protein, TFII-I, raises the possibility of a more general involvement of USF in transcriptional regula- tion. While expression of both USF-1 and USF-2 species is ubiquitous, different ratios of USF homo- and heterodimers are found in different cell types.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-229","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3163","replicate":"1","replicate description":"tier 1","original_filename":"GSM803441_hg19_wgEncodeHaibTfbsK562Usf1V0416101RawRep2.bigWig"},"geolst":["GSM803441"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 USF-1","url":"http://egg.wustl.edu/d/hg19/GSM803441_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24022","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"USF-1","antibody antibodydescription":"Rabbit polyclonal, USF-1 (C-20).","antibody targetdescription":"The ubiquitously expressed cellular upstream stimulatory factor (USF) consists of USF-1 and USF-2 polypeptides which independently exhibit site-specific DNA binding and are members of the c-Myc-related family of regulatory factors containing helix-loop-helix domains. USF also contains a leucine repeat that is required for efficient DNA binding. USF was originally identified as an up- stream stimulatory factor that binds the core sequence CACGTG in the adeno- virus late promoter. These findings, together with the demonstration of coop- erative interaction between USF and the initiator-binding protein, TFII-I, raises the possibility of a more general involvement of USF in transcriptional regula- tion. While expression of both USF-1 and USF-2 species is ubiquitous, different ratios of USF homo- and heterodimers are found in different cell types.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-229","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3163","replicate":"1","replicate description":"tier 1","original_filename":"GSM803441_hg19_wgEncodeHaibTfbsK562Usf1V0416101RawRep1.bigWig"},"geolst":["GSM803441"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 Pol2-4H8","url":"http://egg.wustl.edu/d/hg19/GSM803443_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24041","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"Pol2-4H8","antibody antibodydescription":"Mouse monoclonal to RNA polymerase II CTD repeat YSPTSPS antibody (4H8) - ChIP Grade","antibody targetdescription":"This gene encodes the largest subunit of RNA polymerase II, the polymerase responsible for synthesizing messenger RNA in eukaryotes","antibody vendorname":"Abcam","antibody vendorid":"ab5408","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2939","replicate":"1","replicate description":"tier 1","original_filename":"GSM803443_hg19_wgEncodeHaibTfbsK562Pol24h8V0416101RawRep1.bigWig"},"geolst":["GSM803443"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 Pol2-4H8","url":"http://egg.wustl.edu/d/hg19/GSM803443_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24041","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"Pol2-4H8","antibody antibodydescription":"Mouse monoclonal to RNA polymerase II CTD repeat YSPTSPS antibody (4H8) - ChIP Grade","antibody targetdescription":"This gene encodes the largest subunit of RNA polymerase II, the polymerase responsible for synthesizing messenger RNA in eukaryotes","antibody vendorname":"Abcam","antibody vendorid":"ab5408","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2939","replicate":"1","replicate description":"tier 1","original_filename":"GSM803443_hg19_wgEncodeHaibTfbsK562Pol24h8V0416101RawRep2.bigWig"},"geolst":["GSM803443"]},{"type":"bigWig","name":"Harvard ChipSeq K562 TFIIIC-110","url":"http://egg.wustl.edu/d/hg19/GSM935343_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24611","30020"],"details":{"lab":"Harvard","lab description":"Struhl - Harvard University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"TFIIIC-110","antibody antibodydescription":"rabbit polyclonal. Antibody Target: TFIIIC-110","antibody targetdescription":"TFIIIC-110 is a subunit of the RNA Polymerase III transcription factor TFIIIC. Antiserum 4286 was raised by immunizing rabbits with synthetic peptide RPGFSPTSHRLLPTP (human TFIIIC110 residues 897 to 911) coupled to keyhole limpet hemocyanin.","antibody vendorname":"Dr. Robert J. White, Beatson Institute for Cancer Research, UK","antibody vendorid":"4286","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","labversion":"remapped from hg18, Illumina 2.0, low confidence sequences excluded","replicate":"1","original_filename":"GSM935343_hg19_wgEncodeSydhTfbsK562Tf3c110StdSig.bigWig"},"geolst":["GSM935343"]},{"type":"bigWig","name":"Stanford ChipSeq K562 Pol3","url":"http://egg.wustl.edu/d/hg19/GSM935481_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24621","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Pol3","antibody antibodydescription":"mouse monoclonal IgG1. Antibody Target: POL3","antibody targetdescription":"RNA Polymerase III","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-21754","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","labversion":"Illumina 2.0, low confidence sequences excluded","replicate":"1","original_filename":"GSM935481_hg19_wgEncodeSydhTfbsK562Pol3StdSig.bigWig"},"geolst":["GSM935481"]},{"type":"bigWig","name":"Stanford ChipSeq K562 IFNg30","url":"http://egg.wustl.edu/d/hg19/GSM935487_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24620","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNg30","treatment description":"Interferon gamma treatment - 30 minutes (Snyder)","antibody":"STAT1","antibody antibodydescription":"rabbit polyclonal to STAT1 (alpha) p-91 (C-24). Antibody Target: STAT1","antibody targetdescription":"transcription factor, activated by interferon signalling","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-345","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000657","replicate":"1","original_filename":"GSM935487_hg19_wgEncodeSydhTfbsK562Stat1Ifng30StdSig.bigWig"},"geolst":["GSM935487"]},{"type":"bigWig","name":"Stanford ChipSeq K562 CDP","url":"http://egg.wustl.edu/d/hg19/GSM1003622_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24696","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"CDP_(sc-6327)","antibody antibodydescription":"CDP (C-20) is an affinity purified goat polyclonal antibody raised against a peptide mapping at the C-terminus of CDP of mouse origin.","antibody targetdescription":"CDP (for CCAAT displacement protein) was identified as a repressor for tran- scription of developmentally regulated genes. It is a homeodomain protein that appears to compete with transcriptional activating proteins for binding to the promoter regions of various genes. CDP contains three cut repeats which function as DNA binding domains. It has been demonstrated that cut repeat domains have the capacity to bind to DNA in conjunction with or independently of homeodomain DNA binding. CDP has been shown to be the DNA-binding subunit of the HiNF-D complex, which contains cyclin A, Cdc2 and an Rb-related protein in addition to CDP. Histone expression is required for the transition to S phase in the cell cycle. The HiNF-D complex regulates the transcription of Histone H4, H3 and H1 genes, allowing cells to progress from G1 to S phase.","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-6327","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","labversion":"PeakSeq1.0","original_filename":"GSM1003622_hg19_wgEncodeSydhTfbsK562Cdpsc6327IggrabSig.bigWig"},"geolst":["GSM1003622"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 TAF7","url":"http://egg.wustl.edu/d/hg19/GSM803407_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24046","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"TAF7_(SC-101167)","antibody antibodydescription":"Mouse monoclonal IgG, raised against recombinant TAF II p55 (TAF7) of human origin.","antibody targetdescription":"The intronless gene for this transcription coactivator is located between the protocadherin beta and gamma gene clusters on chromosome 5. The protein encoded by this gene is a component of the TFIID protein complex, a complex which binds to the TATA box in class II promoters and recruits RNA polymerase II and other factors. This particular subunit interacts with the largest TFIID subunit, as well as multiple transcription activators. The protein is required for transcription by promoters targeted by RNA polymerase II (RefSeq).","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-101167","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3274","replicate":"1","replicate description":"tier 1","original_filename":"GSM803407_hg19_wgEncodeHaibTfbsK562Taf7sc101167V0416101RawRep1.bigWig"},"geolst":["GSM803407"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 CBX3","url":"http://egg.wustl.edu/d/hg19/GSM1010732_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24685","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Mouse monoclonal IgG, raised against recombinant CBX3 of human origin. Antibody Target: CBX3","antibody targetdescription":"At the nuclear envelope, the nuclear lamina and heterochromatin are adjacent to the inner nuclear membrane. The protein encoded by this gene binds DNA and is a component of heterochromatin. This protein also can bind lamin B receptor, an integral membrane protein found in the inner nuclear membrane. The dual binding functions of the encoded protein may explain the association of heterochromatin with the inner nuclear membrane. This protein binds histone H3 tails methylated at Lys-9 sites. This protein is also recruited to sites of ultraviolet-induced DNA damage and double-strand breaks. Two transcript variants encoding the same protein but differing in the 5' UTR, have been found for this gene.","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-101004","controlid":"SL6023","labexpid":"SL7105,SL7568","softwareversion":"MACS","cell sex":"F","antibody":"CBX3_(SC-101004)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010732_hg19_wgEncodeHaibTfbsK562Cbx3sc101004V0422111RawRep2.bigWig"},"geolst":["GSM1010732"]},{"type":"bigWig","name":"Yale ChipSeq K562 c-Fos","url":"http://egg.wustl.edu/d/hg19/GSM935355_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24608","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"c-Fos","antibody antibodydescription":"Rabbit polyclonal to amino acids 210-335 mapping at the C-terminus of c-Fos of human origin. Antibody Target: c-Fos","antibody targetdescription":"Heterodimer of Fos and Jun constitute transcription factor AP1.  Proto-oncogene c-Jun is a leucine-zipper.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-7202","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","replicate":"1","original_filename":"GSM935355_hg19_wgEncodeSydhTfbsK562CfosStdSig.bigWig"},"geolst":["GSM935355"]},{"type":"bigWig","name":"Yale ChipSeq K562 c-Jun","url":"http://egg.wustl.edu/d/hg19/GSM935411_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24603","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"c-Jun","antibody antibodydescription":"Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun","antibody targetdescription":"Heterodimer of Fos and Jun constitute transcription factor AP1.  Proto-oncogene c-Jun is a leucine-zipper.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-1694","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","replicate":"1","original_filename":"GSM935411_hg19_wgEncodeSydhTfbsK562CjunStdSig.bigWig"},"geolst":["GSM935411"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 CBX3","url":"http://egg.wustl.edu/d/hg19/GSM1010732_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24685","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Mouse monoclonal IgG, raised against recombinant CBX3 of human origin. Antibody Target: CBX3","antibody targetdescription":"At the nuclear envelope, the nuclear lamina and heterochromatin are adjacent to the inner nuclear membrane. The protein encoded by this gene binds DNA and is a component of heterochromatin. This protein also can bind lamin B receptor, an integral membrane protein found in the inner nuclear membrane. The dual binding functions of the encoded protein may explain the association of heterochromatin with the inner nuclear membrane. This protein binds histone H3 tails methylated at Lys-9 sites. This protein is also recruited to sites of ultraviolet-induced DNA damage and double-strand breaks. Two transcript variants encoding the same protein but differing in the 5' UTR, have been found for this gene.","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-101004","controlid":"SL6023","labexpid":"SL7105,SL7568","softwareversion":"MACS","cell sex":"F","antibody":"CBX3_(SC-101004)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010732_hg19_wgEncodeHaibTfbsK562Cbx3sc101004V0422111RawRep1.bigWig"},"geolst":["GSM1010732"]},{"type":"bigWig","name":"SunyAlbany RipSeq K562 T7Tag","url":"http://egg.wustl.edu/d/hg19/GSM944526_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24074","30021"],"details":{"lab":"SunyAlbany","lab description":"Tenenbaum - SUNY at Albany","datatype":"RipSeq","datatype description":"RNA IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"T7Tag","antibody antibodydescription":"1) Mil AB3790 Anti-t7 Epitope tag, T7 (MASMTGGQQMG) 2) Novagen 69522 Negative Control Ab (T7 Tag Mouse Monoclonal). Antibody Target: T7Tag","antibody targetdescription":"Negative Control Ab (T7 Tag Mouse Monoclonal).","antibody vendorname":"1)Millipore","antibody vendorid":"AB3790","labversion":"Nov_69522 antibody","replicate":"1","original_filename":"GSM944526_hg19_wgEncodeSunyRipSeqK562T7tagSigRep1.bigWig"},"geolst":["GSM944526"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 MEF2A","url":"http://egg.wustl.edu/d/hg19/GSM803379_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24030","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"MEF2A","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping at the C-terminus of MEF-2 of human origin.","antibody targetdescription":"The protein encoded by this gene is a DNA-binding transcription factor that activates many muscme-specific, growth factor-induced, and stress-induced genes.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-313","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL1794","replicate":"1","replicate description":"tier 1","original_filename":"GSM803379_hg19_wgEncodeHaibTfbsK562Mef2aV0416101RawRep2.bigWig"},"geolst":["GSM803379"]},{"type":"bigWig","name":"Stanford ChipSeq K562 Pol2","url":"http://egg.wustl.edu/d/hg19/GSM935632_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24003","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Pol2","antibody antibodydescription":"mouse monoclonal, clone 8WG16. Antibody Target: POL2","antibody targetdescription":"RNA Polymerase II","antibody vendorname":"Covance","antibody vendorid":"MMS-126R","control":"IgG-mus","control description":"Input signal from Normal Mouse IgG ChIP-seq.","controlid":"wgEncodeEH000726","labversion":"remapped from hg18, Data paired with IgG_Control.","replicate":"1","original_filename":"GSM935632_hg19_wgEncodeSydhTfbsK562Pol2IggmusSig.bigWig"},"geolst":["GSM935632"]},{"type":"bigWig","name":"Stanford ChipSeq K562 Ini1","url":"http://egg.wustl.edu/d/hg19/GSM935634_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24632","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Ini1","antibody antibodydescription":"Ini1 (C-20) is an affinity purified goat polyclonal antibody raised against a peptide mapping near the C-terminus of Ini1 of human origin. Antibody Target: INI1","antibody targetdescription":"Ini1 (BAF47, SMARCB1) is a ubiquitous 47 kD component of the SWI/SNF chromatin-remodeling complex.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-16189","control":"IgG-mus","control description":"Input signal from Normal Mouse IgG ChIP-seq.","controlid":"wgEncodeEH000726","labversion":"remapped from hg18, Illumina 2.0, low confidence sequences excluded. Data paired with IgG_Control.","replicate":"1","original_filename":"GSM935634_hg19_wgEncodeSydhTfbsK562Ini1IggmusSig.bigWig"},"geolst":["GSM935634"]},{"type":"bigWig","name":"SunyAlbany RipSeq K562 ripInput","url":"http://egg.wustl.edu/d/hg19/GSM944521_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24073","30021"],"details":{"lab":"SunyAlbany","lab description":"Tenenbaum - SUNY at Albany","datatype":"RipSeq","datatype description":"RNA IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"ripInput","antibody antibodydescription":"Total input. Antibody Target: ripInput","antibody targetdescription":"Total input for comparison for RIP experiments","antibody vendorname":"Tenenbaum lab","antibody vendorid":"RIP Input","replicate":"1","original_filename":"GSM944521_hg19_wgEncodeSunyRipSeqK562RipinputSigRep2.bigWig"},"geolst":["GSM944521"]},{"type":"bigWig","name":"SunyAlbany RipSeq K562 ripInput","url":"http://egg.wustl.edu/d/hg19/GSM944521_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24073","30021"],"details":{"lab":"SunyAlbany","lab description":"Tenenbaum - SUNY at Albany","datatype":"RipSeq","datatype description":"RNA IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"ripInput","antibody antibodydescription":"Total input. Antibody Target: ripInput","antibody targetdescription":"Total input for comparison for RIP experiments","antibody vendorname":"Tenenbaum lab","antibody vendorid":"RIP Input","replicate":"1","original_filename":"GSM944521_hg19_wgEncodeSunyRipSeqK562RipinputSigRep1.bigWig"},"geolst":["GSM944521"]},{"type":"bigWig","name":"Stanford ChipSeq K562 SMC3","url":"http://egg.wustl.edu/d/hg19/GSM935310_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24613","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"SMC3_(ab9263)","antibody antibodydescription":"Rabbit polyclonal raised against synthetic peptide representing a portion within the last 100 amino acids of the human Structural Maintenance of Chromosomes-3 conjugated to KLH. Antibody Target: SMC3","antibody targetdescription":"Involved in chromosome cohesion during cell cycle and in DNA repair. Central component of cohesin complex.  The cohesin complex is required for the cohesion of sister chromatids after DNA replication.","antibody vendorname":"Abcam","antibody vendorid":"ab9263","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935310_hg19_wgEncodeSydhTfbsK562Smc3ab9263IggrabSig.bigWig"},"geolst":["GSM935310"]},{"type":"bigWig","name":"Yale ChipSeq K562 Max","url":"http://egg.wustl.edu/d/hg19/GSM935539_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24066","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"Max","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping at the C-terminus of Max of human origin. Antibody Target: Max","antibody targetdescription":"The protein encoded by this gene is a member of the basic helix-loop-helix leucine zipper (bHLHZ) family of transcription factors. It is able to form homodimers and heterodimers with other family members, which include Mad, Mxi1 and Myc. Myc is an oncoprotein implicated in cell proliferation, differentiation and apoptosis. The homodimers and heterodimers compete for a common DNA target site (the E box) and rearrangement among these dimer forms provides a complex system of transcriptional regulation. Multiple alternatively spliced transcript variants have been described for this gene but the full-length nature for some of them is unknown (RefSeq).","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-197","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","replicate":"1","original_filename":"GSM935539_hg19_wgEncodeSydhTfbsK562MaxStdSig.bigWig"},"geolst":["GSM935539"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 CREB1","url":"http://egg.wustl.edu/d/hg19/GSM1010890_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24678","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Mouse monoclonal IgG1","antibody targetdescription":"This gene encodes a transcription factor that is a member of the leucine zipper family of DNA binding proteins. This protein binds as a homodimer to the cAMP-responsive element, an octameric palindrome. The protein is phosphorylated by several protein kinases, and induces transcription of genes in response to hormonal stimulation of the cAMP pathway.  Alternate splicing of this gene results in two transcript variants encoding different isoforms. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-240","controlid":"SL12793","labexpid":"SL13293,SL12420","softwareversion":"MACS","cell sex":"F","antibody":"CREB1_(SC-240)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010890_hg19_wgEncodeHaibTfbsK562Creb1sc240V0422111RawRep2.bigWig"},"geolst":["GSM1010890"]},{"type":"bigWig","name":"Yale ChipSeq K562 NF-E2","url":"http://egg.wustl.edu/d/hg19/GSM935414_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24647","30017"],"details":{"lab":"Yale","lab description":"Snyder - Yale University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"NF-E2","antibody antibodydescription":"Rabbit polyclonal, epitope mapping at the C-terminus of NF-E2 of mouse origin and recommended for detection of protein of rat, mouse and human origin. Antibody Target: NF-E2","antibody targetdescription":"Nuclear factor, erythroid-derived 2","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-291","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","replicate":"1","original_filename":"GSM935414_hg19_wgEncodeSydhTfbsK562Nfe2StdSig.bigWig"},"geolst":["GSM935414"]},{"type":"bigWig","name":"Stanford ChipSeq K562 IFNa30","url":"http://egg.wustl.edu/d/hg19/GSM935521_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24603","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNa30","treatment description":"30 m of Interferon alpha (Snyder)","antibody":"c-Jun","antibody antibodydescription":"Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun","antibody targetdescription":"Heterodimer of Fos and Jun constitute transcription factor AP1.  Proto-oncogene c-Jun is a leucine-zipper.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-1694","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000655","replicate":"1","original_filename":"GSM935521_hg19_wgEncodeSydhTfbsK562CjunIfna30StdSig.bigWig"},"geolst":["GSM935521"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 RevXlinkChromatin","url":"http://egg.wustl.edu/d/hg19/GSM803352_3.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24017","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"RevXlinkChromatin","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL518","labexpid":"SL518","replicate":"1","replicate description":"tier 1","original_filename":"GSM803352_hg19_wgEncodeHaibTfbsK562RxlchPcr1xRawRep3.bigWig"},"geolst":["GSM803352"]},{"type":"bigWig","name":"Harvard ChipSeq K562 RPC155","url":"http://egg.wustl.edu/d/hg19/GSM935372_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24645","30020"],"details":{"lab":"Harvard","lab description":"Struhl - Harvard University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"RPC155","antibody antibodydescription":"Rabbit polyclonal - Antiserum 1900 was raised by immunizing rabbits with synthetic peptide PKRPLTFDTNEFHIPLVT (residues 1374?1391 of the RPC155 subunit of human pol III) coupled to KLH. Antibody Target: RPC155","antibody targetdescription":"polymerase (RNA) III (DNA directed) polypeptide A, 155kDa","antibody vendorname":"Donated by Dr. RJ White, The Beatson Institute for Cancer Research","antibody vendorid":"1900","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000615","labversion":"Illumina 2.0, low confidence sequences excluded, fragmented with both a probe sonicator and a Misonix sonicator, and precipitated with protein A sepharose beads","replicate":"1","original_filename":"GSM935372_hg19_wgEncodeSydhTfbsK562Rpc155StdSig.bigWig"},"geolst":["GSM935372"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 FOSL1","url":"http://egg.wustl.edu/d/hg19/GSM803439_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24032","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"FOSL1_(SC-183)","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping at the N-terminus of FOSL1 of human origin.","antibody targetdescription":"The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2.  These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1.  As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-183","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2349","replicate":"1","replicate description":"tier 1","original_filename":"GSM803439_hg19_wgEncodeHaibTfbsK562Fosl1sc183V0416101RawRep2.bigWig"},"geolst":["GSM803439"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 FOSL1","url":"http://egg.wustl.edu/d/hg19/GSM803439_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24032","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"FOSL1_(SC-183)","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping at the N-terminus of FOSL1 of human origin.","antibody targetdescription":"The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2.  These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1.  As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. (provided by RefSeq)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-183","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL2349","replicate":"1","replicate description":"tier 1","original_filename":"GSM803439_hg19_wgEncodeHaibTfbsK562Fosl1sc183V0416101RawRep1.bigWig"},"geolst":["GSM803439"]},{"type":"bigWig","name":"Stanford ChipSeq K562 p300","url":"http://egg.wustl.edu/d/hg19/GSM935401_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24011","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"p300","antibody antibodydescription":"Rabbit Polyclonal. Antibody Target: P300","antibody targetdescription":"EP300(c-20)","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-585","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935401_hg19_wgEncodeSydhTfbsK562P300IggrabSig.bigWig"},"geolst":["GSM935401"]},{"type":"bigWig","name":"Stanford ChipSeq K562 CTCF","url":"http://egg.wustl.edu/d/hg19/GSM935407_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24001","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"CTCF_(SC-15914)","antibody antibodydescription":"Goat polyclonal, epitope mapping near the C-terminus of CTCF of human origin. Antibody Target: CTCF","antibody targetdescription":"Transcriptional regulator with 11 highly conserved zinc finger domains. Depending on context, can bind a histone acetyltransferase (HAT)-containing complex and function as transcriptional activator or bind a histone deacetylase (HDAC)-containing complex and function as transcriptional repressor. Involved in transcriptional regulation by binding to chromatin insulators and preventing interaction between promoter and nearby enhancers and silencers. Preferentially interacts with unmethylated DNA, preventing spreading of CpG methylation. Can dimerize, mediating long-range chromatin looping. When bound to chromatin, provides an anchor point for nucleosomes positioning. Involved in sister chromatid cohesion. Associates with both centromeres and chromosomal arms during metaphase and required for cohesin localization to CTCF sites.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-15914","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","replicate":"1","original_filename":"GSM935407_hg19_wgEncodeSydhTfbsK562CtcfbIggrabSig.bigWig"},"geolst":["GSM935407"]},{"type":"bigWig","name":"UChicago ChipSeq K562 eGFP-NR4A1","url":"http://egg.wustl.edu/d/hg19/GSM777637_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24010","30013"],"details":{"lab":"UChicago","lab description":"White - University of Chicago","data type":"ChipSeq","data type description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"eGFP-NR4A1","antibody antibody description":"Goat polyclonal","antibody target description":"NR4A1","antibody vendor name":"Kevin White","antibody vendor id":"(None)","control":"Control_eGFP-NR4A1","control description":"This data represents a control being compared to experiments using antibody eGFP-NR4A1","control id":"K562/Input/Control_eGFP-NR4A1","replicate":"1","replicate description":"tier 1","original_filename":"GSM777637_wgEncodeUchicagoTfbsK562Enr4a1ControlSig.bigWig"},"geolst":["GSM777637"]},{"type":"bigWig","name":"UT-A ChipSeq K562 CTCF","url":"http://egg.wustl.edu/d/hg19/GSM822311_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24001","30009"],"details":{"lab":"UT-A","lab description":"Iyer - University of Texas at Austin","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"CTCF","antibody antibodydescription":"rabbit polyclonal","antibody targetdescription":"CTCF zinc finger transcription factor. A sequence specific DNA binding protein that functions as an insulator, blocking enhancer activity. It has also been suggested to block the spreading of chromatin structure in certain instances.","antibody vendorname":"Millipore","antibody vendorid":"07-729","controlid":"K562/Input","labversion":"align_on_cluster_bwa.pl v 1","replicate":"1","replicate description":"tier 1","original_filename":"GSM822311_hg19_wgEncodeOpenChromChipK562CtcfSig.bigWig"},"geolst":["GSM822311"]},{"type":"bigWig","name":"UT-A ChipSeq K562 CTCF","url":"http://egg.wustl.edu/d/hg19/GSM822311_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24001","30009"],"details":{"lab":"UT-A","lab description":"Iyer - University of Texas at Austin","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"CTCF","antibody antibodydescription":"rabbit polyclonal","antibody targetdescription":"CTCF zinc finger transcription factor. A sequence specific DNA binding protein that functions as an insulator, blocking enhancer activity. It has also been suggested to block the spreading of chromatin structure in certain instances.","antibody vendorname":"Millipore","antibody vendorid":"07-729","controlid":"K562/Input","labversion":"align_on_cluster_bwa.pl v 1","replicate":"1","replicate description":"tier 1","original_filename":"GSM822311_hg19_wgEncodeOpenChromChipK562CtcfBaseOverlapSignal.bigWig"},"geolst":["GSM822311"]},{"type":"bigWig","name":"Broad ChipSeq K562 CBP","url":"http://egg.wustl.edu/d/hg19/GSM1003574_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24703","30003"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Rabbit polyclonal, epitope mapping at the N-terminus of CBP of human origin. Antibody Target: CBP","antibody targetdescription":"CBP is a histone acetyl transferase that promotes transcription.  CBP is recruited by a variety of transcription factors to promoters and enhancers.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc369","controlid":"K562/None/Input/std","replicate":"1","softwareversion":"ScriptureVPaperR3","cell sex":"F","antibody":"CBP_(sc-369)","treatment":"None","treatment description":"No special treatment or protocol applies","control":"std","control description":"Standard input signal for most experiments.","labversion":"Illumina_GA2x","labversion description":"Illumina Genome Analyzer IIx","original_filename":"GSM1003574_hg19_wgEncodeBroadHistoneK562Cbpsc369Sig.bigWig"},"geolst":["GSM1003574"]},{"type":"bigWig","name":"Stanford ChipSeq K562 IFNa6h","url":"http://egg.wustl.edu/d/hg19/GSM935504_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24652","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"IFNa6h","treatment description":"Interferon alpha treatment - 6 hours (Snyder)","antibody":"IRF1","antibody antibodydescription":"IRF-1 (C-20) is an affinity purified rabbit polyclonal antibody raised against a peptide mapping at the C-terminus of IRF-1 of human origin. Antibody Target: IRF1","antibody targetdescription":"Interferon regulatory factor 1 is a member of the interferon regulatory transcription factor (IRF) family. IRF1 serves as an activator of interferons alpha and beta transcription and also functions as a transcription activator of genes induced by interferons alpha, beta, and gamma. IRF1 has been shown to play roles in regulating apoptosis and tumor suppression.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-497","control":"std","control description":"Standard input signal for most experiments.","controlid":"wgEncodeEH000656","replicate":"1","original_filename":"GSM935504_hg19_wgEncodeSydhTfbsK562Irf1Ifna6hStdSig.bigWig"},"geolst":["GSM935504"]},{"type":"bigWig","name":"Stam K562 CTCF 1","url":"http://egg.wustl.edu/d/hg19/GSM749690_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24001","30004"],"details":{"cell":"K562","cell organism":"Human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"CTCF","antibody description":"rabbit polyclonal","antibody target description":"CTCF zinc finger transcription factor. A sequence specific DNA binding protein that functions as an insulator, blocking enhancer activity. It has also been suggested to block the spreading of chromatin structure in certain instances.","antibody vendor name":"Millipore","replicate":"1","original_filename":"GSM749690_hg19_wgEncodeUwTfbsK562CtcfStdRawRep1.bigWig"},"geolst":["GSM749690"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 CEBPD","url":"http://egg.wustl.edu/d/hg19/GSM1010906_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24689","30015"],"details":{"datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","antibody antibodydescription":"Rabbit polyclonal IgG, epitope mapping at the C-terminus of CEBPD of human origin. Antibody Target: CEBPD","antibody targetdescription":"The protein encoded by this intronless gene is a bZIP transcription factor which can bind as a homodimer to certain DNA regulatory regions. It can also form heterodimers with the related protein CEBP-alpha. The encoded protein is important in the regulation of genes involved in immune and inflammatory responses, and may be involved in the regulation of genes associated with activation and/or differentiation of macrophages. The cytogenetic location of this locus has been reported as both 8p11 and 8q11 (provided by RefSeq).","antibody vendorname":"Santa Cruz Biotechnology","antibody vendorid":"sc-636","controlid":"SL12793,SL11659","labexpid":"SL13317,SL11280","softwareversion":"MACS","cell sex":"F","antibody":"CEBPD_(SC-636)","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v042211.1","protocol description":"Faster ChIP protocol & AMpure XP size selection for ChIP-seq (Myers)","replicate":"1,2","original_filename":"GSM1010906_hg19_wgEncodeHaibTfbsK562Cebpdsc636V0422111RawRep2.bigWig"},"geolst":["GSM1010906"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 Sin3Ak-20","url":"http://egg.wustl.edu/d/hg19/GSM803525_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24054","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"Sin3Ak-20","antibody antibodydescription":"Rabbit polyclonal, Sin3A (k-20).","antibody targetdescription":"Co-repressor interacting with HDAC1, N-coR, SMRT, and MeCP2","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-994","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"v041610.1","protocol description":"2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers)","controlid":"SL2455","labexpid":"SL3273","replicate":"1","replicate description":"tier 1","original_filename":"GSM803525_hg19_wgEncodeHaibTfbsK562Sin3ak20V0416101RawRep2.bigWig"},"geolst":["GSM803525"]},{"type":"bigWig","name":"USC ChipSeq K562 ZNF274","url":"http://egg.wustl.edu/d/hg19/GSM935503_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24070","30016"],"details":{"lab":"USC","lab description":"Farnham - University of Southern California","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"ZNF274_(M01)","antibody antibodydescription":"Mouse monoclonal antibody raised against a partial recombinant ZNF274 (corresponding to amino acids 420-531 of the human ZNF274 protein). Antibody Target: ZNF274","antibody targetdescription":"ZNF274 is a zinc finger protein containing five C2H2-type zinc finger domains, two Kruppel-associated box A (KRABA) domains, and a leucine-rich SCAN domain. The encoded protein has been suggested to be a transcriptional repressor and interacts with the KAP1 corepressor complex.","antibody vendorname":"Abnova ZNF74","antibody vendorid":"H00010782-M01","control":"UCDavis","control description":"Input library was prepared at UC Davis.","controlid":"wgEncodeEH000672","replicate":"1","original_filename":"GSM935503_hg19_wgEncodeSydhTfbsK562Znf274m01UcdSig.bigWig"},"geolst":["GSM935503"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 SP1","url":"http://egg.wustl.edu/d/hg19/GSM803505_2.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24027","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"SP1","antibody antibodydescription":"Sp1(E-3) is a mouse monoclonal antibody raised against amino acids 121-345 mapping near the N-terminus of Sp1 ofhuman origin. Recommended for detection of Sp1 of m, r and h origin by WB, IP, IF and ELISA.","antibody targetdescription":"SP1 is a transcription factor that binds to GC box promoters elements and selectively activates mRNA synthesis from genes that contain functional recognition sites. It can interact with G/C-rich motifs from the serotonin receptor promoter.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-17824","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL2455","labexpid":"SL1197","replicate":"1","replicate description":"tier 1","original_filename":"GSM803505_hg19_wgEncodeHaibTfbsK562Sp1Pcr1xRawRep2.bigWig"},"geolst":["GSM803505"]},{"type":"bigWig","name":"HudsonAlpha ChipSeq K562 SP1","url":"http://egg.wustl.edu/d/hg19/GSM803505_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24027","30015"],"details":{"lab":"HudsonAlpha","lab description":"Myers - Hudson Alpha Institute for Biotechnology","datatype":"ChipSeq","datatype description":"ChIP-Seq","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","antibody":"SP1","antibody antibodydescription":"Sp1(E-3) is a mouse monoclonal antibody raised against amino acids 121-345 mapping near the N-terminus of Sp1 ofhuman origin. Recommended for detection of Sp1 of m, r and h origin by WB, IP, IF and ELISA.","antibody targetdescription":"SP1 is a transcription factor that binds to GC box promoters elements and selectively activates mRNA synthesis from genes that contain functional recognition sites. It can interact with G/C-rich motifs from the serotonin receptor promoter.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-17824","treatment":"None","treatment description":"No special treatment or protocol applies","protocol":"PCR1x","protocol description":"1-cycle of PCR (Myers)","controlid":"SL2455","labexpid":"SL1197","replicate":"1","replicate description":"tier 1","original_filename":"GSM803505_hg19_wgEncodeHaibTfbsK562Sp1Pcr1xRawRep1.bigWig"},"geolst":["GSM803505"]},{"type":"bigWig","name":"Stanford ChipSeq K562 c-Jun","url":"http://egg.wustl.edu/d/hg19/GSM1003609_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":0,"pb":230,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":25,"summeth":1},"annotation":["14018","24603","30018"],"details":{"lab":"Stanford","lab description":"Snyder - Stanford University","datatype":"ChipSeq","datatype description":"Chromatin IP Sequencing","cell":"K562","cell organism":"human","cell description":"leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell karyotype":"cancer","cell lineage":"mesoderm","cell sex":"F","treatment":"None","treatment description":"No special treatment or protocol applies","antibody":"c-Jun","antibody antibodydescription":"Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun","antibody targetdescription":"Heterodimer of Fos and Jun constitute transcription factor AP1.  Proto-oncogene c-Jun is a leucine-zipper.","antibody vendorname":"Santa Cruz Biotech","antibody vendorid":"sc-1694","control":"IgG-rab","control description":"Input signal from Normal Rabbit IgG ChIP-seq.","controlid":"wgEncodeEH001795","original_filename":"GSM1003609_hg19_wgEncodeSydhTfbsK562CjunIggrabSig.bigWig"},"geolst":["GSM1003609"]},{"type":"bigWig","name":"Stam K562 2","url":"http://egg.wustl.edu/d/hg19/GSM736566_1.bigWig","public":true,"mode":1,"qtc":{"anglescale":1,"pr":0,"pg":77,"pb":0,"nr":255,"ng":0,"nb":0,"pth":"#ffff00","nth":"#800000","thtype":1,"thmin":0,"thmax":10,"thpercentile":90,"height":20,"summeth":1},"annotation":["14018","23001","30004"],"details":{"cell":"K562","cell organism":"Human","cell description":"leukemia","cell karyotype":"cancer","cell lineage":"The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC","cell sex":"F","replicate":"2","original_filename":"GSM736566_hg19_wgEncodeUwDnaseK562RawRep2.bigWig"},"geolst":["GSM736566"]},{"type":"native_track","list":[{"name":"refGene","mode":3,"qtc":{"anglescale":1,"pr":0,"pg":77,"pb":0,"nr":0,"ng":0,"nb":230,"pth":"#800000","nth":"#000099","thtype":0,"thmin":0,"thmax":10,"thpercentile":95,"height":50,"summeth":1,"textcolor":"rgb(0,0,0)","fontsize":"8pt","fontfamily":"sans-serif","fontbold":false,"bedcolor":"rgb(0,77,153)"}},{"name":"rmsk_ensemble","mode":1,"qtc":{"anglescale":1,"height":30},"categories":{"1":["SINE - short interspersed nuclear elements","#cc0000"],"2":["LINE - long interspersed nuclear element","#FF6600"],"3":["LTR - long terminal repeat element","#006600"],"4":["DNA transposon","#4A72E8"],"5":["Simple repeat, micro-satellite","#AB833B"],"6":["Satellite repeat","#660000"],"7":["Low complexity repeat","#663333"],"8":["RNA repeat","#cc33ff"],"9":["Other repeats","#488E8E"],"10":["Unknown","#5C5C5C"],"-1":["no information","transparent"]}}]},{"type":"run_genesetview","list":[{"c":"chrX","a":153357647,"a1":153357647,"b":153358631,"b1":153358631,"isgene":true,"name":"F3","strand":"+"},{"c":"chr7","a":560885,"a1":560885,"b":560915,"b1":560915,"isgene":true,"name":"PDGFA","strand":"+"},{"c":"chr11","a":69378896,"a1":69378896,"b":69379848,"b1":69379848,"isgene":true,"name":"PRE2","strand":"+"},{"c":"chr1","a":115571965,"a1":115571965,"b":115572317,"b1":115572317,"isgene":true,"name":"TSHB","strand":"+"},{"c":"chrX","a":11551258,"a1":11551258,"b":11551587,"b1":11551587,"isgene":true,"name":"T39","strand":"+"}],"viewrange":["F3",153357647,"T39",11551584]},{"type":"geneset_ripe","list":[{"name":"coordinatesofsilencer-geneset.bed","lst":[{"c":"chrX","a":153357647,"b":153358631,"isgene":false,"name":"F3","a1":153357647,"b1":153358631},{"c":"chr7","a":560885,"b":560915,"isgene":false,"name":"PDGFA","a1":560885,"b1":560915},{"c":"chr11","a":69378896,"b":69379848,"isgene":false,"name":"PRE2","a1":69378896,"b1":69379848},{"c":"chr1","a":115571965,"b":115572317,"isgene":false,"name":"TSHB","a1":115571965,"b1":115572317},{"c":"chrX","a":11551258,"b":11551587,"isgene":false,"name":"T39","a1":11551258,"b1":11551587}],"gss_down":2500,"gss_opt":"genebody","gss_origin":"txstart","gss_up":2500}]},{"type":"metadata","vocabulary":{"View":["Default_View","macs2signal_pval","macs2signal_foldChange","narrowPeak","broadPeak","gappedPeak","Auxiliary_segmentation","Imputed_segmentation"],"Type":["Real","Imputed"],"EID":["E001","E002","E003","E004","E005","E006","E007","E008","E009","E010","E011","E012","E013","E014","E015","E016","E017","E018","E019","E020","E021","E022","E023","E024","E025","E026","E027","E028","E029","E030","E031","E032","E033","E034","E035","E036","E037","E038","E039","E040","E041","E042","E043","E044","E045","E046","E047","E048","E049","E050","E051","E052","E053","E054","E055","E056","E057","E058","E059","E061","E062","E063","E065","E066","E067","E068","E069","E070","E071","E072","E073","E074","E075","E076","E077","E078","E079","E080","E081","E082","E083","E084","E085","E086","E087","E088","E089","E090","E091","E092","E093","E094","E095","E096","E097","E098","E099","E100","E101","E102","E103","E104","E105","E106","E107","E108","E109","E110","E111","E112","E113","E114","E115","E116","E117","E118","E119","E120","E121","E122","E123","E124","E125","E126","E127","E128","E129"],"Data format":["BED","bigWig","bedGraph","interaction","categorical","methylC","Hammock","BAM"]},"source":"http://epigenomecloud.wustl.edu/roadmap/roadmap_integrative_03282014.json","termname":{},"termcolor":{},"termdesc":{}}]